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ABSTRACT 
 
 
Since the first antibiotics became widely available 60 years ago, they have been 
used aggressively. However, bacterial infections continue to be significant clinical 
problems both in hospital and community settings. Bacterial pathogens have become 
increasingly resistant to a variety of antibiotics. They can acquire resistance genes, even 
from distant related genera. Even the common resident (commensal) bacteria of the 
human colon can carry and transfer antibiotic resistance elements to each other, or to 
human pathogens. Bacteroides spp. organisms, the most predominant commensal bacteria 
in the human gut, harbor a plethora of these elements, many of which are mobile 
(transmissible); thus Bacteroides spp. are considered to be reservoirs of antibiotic 
resistance genes. Mobile elements are transferred within and from the Bacteroides spp. 
primarily by conjugation. One important approach to prevent the dissemination of 
antibiotic resistance is to design drugs to disrupt the conjugation apparatus in the 
Bacteroides spp. However, little is known about the molecular mechanism of this 
machinery in Bacteroides spp. 
Previously, our laboratory identified BTF-37, a 37kb conjugative transposon, 
from the B. fragilis clinical isolate LV23. BTF-37 encodes conjugal apparatus proteins 
and confers mobility to non-mobile plasmids. BctA, a highly conserved ORF on BTF-37, 
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encodes a potential coupling protein, the “gatekeeper” that couples transferring DNA 
molecules to the membrane-associated conjugal apparatus. Studies from our laboratory 
have shown that BctA is required for conjugation. One other gene on BTF-37 is orf7, 
whose product ORF7 is also called TraM since it is a closely related homolog of a 
previously identified, but unstudied putative conjugal apparatus protein harbored on the 
transposon CTn341.  
In this study, we demonstrated that TraM exhibits characteristics of a required 
conjugal apparatus protein including 1) sequence conservation with other Bacteroides 
spp. conjugal apparatus proteins; 2) upregulated expression under conjugation conditions; 
3) localization to the bacterial inner membrane; 4) interaction with the putative coupling 
protein BctA and the relaxase BmpH; and 5) absolute requirement for DNA transfer 
within and from B. fragilis LV23. Sequence alignment, quantitative PCR, localization 
studies, protein interaction studies and RNA antisense studies were performed to examine 
the above characteristics. Moreover, mutagenesis and protein interaction studies revealed 
that two amino acids (F66 and L123) in two predicted coiled-coil domains of TraM were 
required for TraM interaction with BctA, suggesting that these two amino acids may be 
essential for TraM function in mediating DNA transfer in B. fragilis. In addition, we also 
identified a different amino acid, L123, as being important for the interaction of TraM 
with the relaxase BmpH. These results suggest that there are likely complex mechanisms 
involved in the interaction between TraM and BctA and/or BmpH, to facilitate DNA 
transfer efficiently within and from B. fragilis.  
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This study represents the first in-depth characterization of a conjugal apparatus 
protein in B. fragilis, and will be useful for future studies aimed at developing 
interventions to prevent dissemination of antibiotic resistance from Bacteroides spp. to 
other bacteria. Moreover, this is one of very few studies using RNA antisense technology 
to knock-down target gene expression in anaerobes, and has avoided the known difficulty 
in genetically manipulating DNA in these organisms.  
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CHAPTER I 
INTRODUCTION 
 
 
One of the biggest battles that humans have ever faced is the battle against 
infectious diseases. With rapid technology development, we thought that we could 
conquer all diseases. However, no matter how technologies develop, microbes mutate 
themselves to adapt and survive most treatments. In addition, they can also multiply 
rapidly and transfer their adaptation characteristics to others. It is likely not efficient to 
simply increase direct approaches to kill microbes. More efforts need to be focused on 
other directions, specifically those designed to prevent microbial adaptation to treatments, 
and to prevent the dissemination of adaptation traits amongst microbes.  
One challenge that we encounter is the emergence and spread of bacteria that are 
resistant to a broad range of “first-line” antibiotics (74, 75, 161, 170, 180). These include 
bacterial infections that contribute most to human diseases: diarrhoeal diseases, 
respiratory tract infections, meningitis, sexually transmitted infections, and hospital-
acquired infections. Some examples include penicillin-resistant Streptococcus 
pneumoniae, vancomycin-resistant enterococci, methicillin-resistant Staphylococcus 
aureus, multi-resistant salmonellae, and multi-resistant Mycobacterium tuberculosis. The 
consequences are severe. Treatments fail to treat infections caused by resistant bacteria, 
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resulting in prolonged illness and greater risk of death. Treatment failures also lead to 
longer periods of infectivity, which increase the numbers of infected people moving in 
the community. As a consequence, the general population is exposed to the risk of 
acquiring a resistant strain during infection. Moreover, when infections become resistant 
to first-line antibiotics, treatment has to be switched to second- or third-line drugs, which 
are much more expensive and sometimes more toxic. In many countries, this is also 
unaffordable.  As a result, some diseases can no longer be treated in areas where 
resistance to first-line drugs is widespread. Moreover, bacteria will finally adapt to resist 
even the latest drugs. Humans may come to a point when no available drug can treat 
certain diseases. Therefore, alternative approaches to prevent the dissemination of 
antibiotic resistance elements are smart choices. 
Bacteria are particularly efficient at disseminating the effects of resistance, partly 
because they can transfer their resistance genes to others. Of immense concern, even 
common resident (commensal) bacteria of the human colon can carry and transfer 
antibiotic resistance elements to other bacteria, including human pathogens (189). 
Moreover, the most predominant commensal bacteria of the gut, Bacteroides species 
(spp.), are considered the reservoir of antibiotic resistance elements (151, 152, 161). 
Nearly 100% of all Bacteroides spp. clinical isolates are now resistant to tetracycline 
(126, 127). Many of them are resistant to β-lactam antibiotics (penicillin, ampicillin, 
cephalosporins, cefoxitin, cephamycins and carbapenems), metronidazole and the 
macrolide-lincosamide-streptogramin (MLS) group of antibiotics (erythromycin and 
clindamycin) (161, 192). All of these resistant traits have been found on transmissible 
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genetic elements (161). Over the past 3 decades, carriage of the tetracycline resistance 
gene, tetQ, has increased from about 30% to nearly 100% of strains (161). The fact that 
these resistance determinants are prevalent and found on transmissible elements in 
Bacteroides spp., particularly conjugative transposons (161), raised the concern that 
Bacteroides spp. may act as reservoirs of antibiotic resistance genes, which would then 
be transferred to other bacterial species. The primary means for Bacteroides spp. to pass 
on their resistance genes to other bacteria is "conjugation", whereby the genetic material 
carrying antibiotic resistance genes is transferred from one bacterium to another (151, 
192). It would be useful if we understood the conjugation machinery of Bacteroides spp., 
and designed preventions to disrupt the formation or action of the conjugation process. 
This would help prevent the dissemination of antibiotic resistance genes in bacteria. 
However, very little is known about the molecular mechanism of conjugation in 
Bacteroides spp. 
To gain deeper understanding of conjugation mechanism in Bacteroides spp., this 
study focused on characterization of TraM, an important protein required for conjugation 
in Bacteroides fragilis (B. fragilis), the most common anaerobic pathogen isolated in 
human bacterial infections (62). 
Conjugation involves two major sets of events: initiation (DNA processing) and 
conjugal apparatus formation. 
DNA processing includes binding, nicking and unwinding of the DNA, 
independent of conjugal apparatus formation (89, 134). This process occurs via the 
relaxosome, a nucleoprotein complex composed of specific proteins (mobilization 
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proteins) covalently linked to the 5’ end of the DNA molecule to be transferred (133, 
135). A relaxase, the major mobilization protein, nicks the DNA to be transferred at its 
origin of transfer (oriT) (89, 134). This nicked DNA is unwound and transmitted in single 
stranded copy with 5’-3’ polarity from the donor to the recipient (89). The passage from 
the donor to the recipient occurs through a specialized membrane-traversing channel 
called the conjugal apparatus. 
The conjugal apparatus (CA) is a multi-protein channel that is assembled across 
donor and recipient cell membranes during conjugation for DNA transferring (63, 154). 
Although the formation of the conjugal apparatus is well studied in Agrobacterium 
tumefaciens Ti plasmids and E. coli F and RP4 plasmids, little is known about its 
structure and function in the Bacteroides spp. In E. coli and Agrobacterium tumefaciens, 
this membrane channel is formed by 10-12 proteins (4, 63, 99, 100). In Agrobacterium 
spp., each of these proteins has been extensively characterized (26, 29). However, the 
Bacteroides spp. CA in even the best-studied elements is still poorly understood. To date, 
the only detailed description of CA-encoding genes in Bacteroides spp. is from Smith 
C.J. et al., who assessed the requirement of each CA gene of the CTn341 isolated from B. 
vulgatus for DNA conjugation by creating deletion mutants (7). 
Previously, our laboratory reported the capture of BTF-37, a 37kb conjugative 
transposon, from a clinical B. fragilis isolate, LV23 (181). Due to A-T rich regions, only 
16kb of BTF-37 was sequenced. This 16kb region carries 11 open reading frames 
(ORFs). By sequence homology analysis with other Bacteroides known transfer factors, 
and by RT-PCR studies, these 11 genes correspond to the transfer region of BTF-37 (77). 
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In this work, RT-PCR studies showed that the transcripts of all of these 11 genes were 
up-regulated when LV23 cells were stimulated with tetracycline. One of these 11 ORFs, 
bctA, is an ORF highly conserved between different Bacteroides spp. transposons. BctA 
encodes a putative coupling protein, the “gatekeeper” that couples transferring DNA 
molecules to the membrane-associated conjugal apparatus, of BTF-37 CTn (77). We also 
showed that BctA was required for transfer of BTF-37 (77). 
BmpH is a relaxase encoded by the mobilizable transposon Tn5520 that was also 
isolated from B. fragilis clinical isolate LV23 (182, 183). Studies from our laboratory 
have shown that BmpH is a relaxase protein that is required for the formation and 
function of the relaxosome, required for the mobility of Tn5520 (182). 
We then identified ORF7, a Bacteroides spp. TraM homologous protein, as an 
important conjugal apparatus protein. TraM is a 393 amino acid protein, and has 92% 
sequence identity to TraM from B. fragilis NCTC9343, 61% sequence similarity to TraM 
of B. fragilis YCH46 and 32% identity to TraM of B. thetaiotaomicron CTnDOT. 
In this study, we demonstrated that TraM exhibits characteristics of a required 
conjugal apparatus protein including 1) sequence conservation with other Bacteroides 
spp. conjugal apparatus proteins; 2) upregulated expression under conjugation conditions; 
3) localization to the bacterial inner membrane; 4) interaction with the putative coupling 
protein BctA and the relaxase BmpH; and 5) requirement for DNA transfer within and 
from B. fragilis LV23. Sequence alignment, quantitative PCR, localization studies, 
protein interaction studies and RNA antisense studies were performed to examine the 
above characteristics. Moreover, mutagenesis and protein interaction studies revealed that 
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two amino acids (F66 and L123) in two predicted coiled-coil domains of TraM were 
required for TraM interaction with BctA, suggesting that these two amino acids may be 
essential for TraM function in mediating DNA transfer in B. fragilis. We also identified 
another amino acid, L123, as being important for the interaction of TraM with the 
relaxase BmpH. 
This study represents the first in depth characterization of a conjugal apparatus 
protein in B. fragilis, which will be useful for future studies aimed at developing 
interventions to prevent dissemination of antibiotic resistance from Bacteroides spp. to 
other bacteria. Moreover, this is one of very few studies using RNA antisense technology 
to knock-down target gene expression in anaerobes, avoiding the difficulty in modifying 
genes in these genera.  
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Figure 1. Bacteroides relaxosome and conjugal apparatus structural model, based on 
studies in E. coli. Adapted from Christie, Nature, 2009 (28).  
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CHAPTER II 
LITERATURE REVIEW 
 
 
Antibiotics and Antibiotic Resistance 
 
Antibiotics are drugs that act to kill bacteria or to inhibit their growth. For 
thousands of years, many ancient cultures (Chinese, Greek, Egyptians) used plants or 
molds with antimicrobial properties to treat infections.  However, it was not until early in 
the twentieth century that natural antibiotics produced by microorganisms were 
discovered. In 1928, the British microbiologist Sir Alexander Fleming made a chance 
discovery of the first antibiotic, penicillin, from the common bread mold Penicillium 
growing on a culture of Staphylococcus aureus (187). By the 1940s, penicillin was 
available for medical use and was successfully used to treat infections in soldiers during 
the World War II. Penicillin has since been commonly used to treat a wide range of 
infections including ulcers, diphtheria, gonorrhea, meningitis, pneumonia, syphilis and 
tuberculosis (8). Since then, many more antibiotics have been isolated from fungi (molds) 
and bacteria. One group of bacteria, the Streptomyces, produces most of the medically 
important antibiotics, such as quinolones, spectinomycin, tetracycline, and streptomycin 
(186). Moreover, with the development of medical chemistry, many semi-synthetic and 
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novel synthetic antibiotics were also introduced into clinical practice (162). It has been 
estimated in 2002 that 100,000- 200,000 tons per annum, and, a total of more than one 
million tons of antibiotics have been applied worldwide in human and animals since the 
1940s (194). 
Antibiotics can be classified based on their mode of action, structure or spectrum 
of activity. They can be bactericidal (kill susceptible bacteria), or bacteriostatic (inhibit 
bacterial growth). Most antibiotics target bacterial functions or growth processes. They 
can target the bacterial cell wall (penicillins, cephalosporins), cell membrane 
(polymixins), protein synthesis (the aminoglycosides, macrolides, and tetracyclines), and 
nucleic acid synthesis and function (rifampicin, quinolones) (46). Narrow-spectrum 
antibiotics target particular types of bacteria, such as Gram-negative or Gram-positive 
bacteria, while broad-spectrum antibiotics affect a wide range of bacteria. 
The extreme efficiency of antibiotics in clearing bacteria led many to believe that 
infectious diseases would be completely wiped out. However, the golden age of 
antibiotics did not last long. During the past few decades, many strains of bacteria have 
evolved and disseminated resistance to antibiotics. Just a few years after the mass 
introduction of penicillin, i.e., by 1950, 40% of hospital Staphylococcus aureus isolates 
were penicillin resistant; and by 1960, this had risen to 80% (24). In 1980, it was 
estimated that 3-5% of Streptococus pneumoniae were penicillin resistant and 34% of S. 
pneumoniae samples were resistant to penicillin (41). Antibiotic resistance by other 
organisms reflects the same trend. Tetracyline was introduced in the 1950s and quickly 
became one of the most widely prescribed broad-spectrum antibiotics. However, 
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tetracycline resistance by normal human intestinal flora has exploded from 2% in the 
1950s to 80% in the 1990s (161). Kanamycin, an antibiotic used in the 1950s, has 
become clinically useless due to the abundance of kanamycin resistant bacteria. 
Dangerously, the emergence of many strains of multidrug resistant bacteria has become a 
major clinical problem, complicating the treatment of bacterial infections and leading to 
increased mortality (39, 112, 117, 152). Many strains of Staphylococcus aureus, a major 
cause of deadly infections in hospitals, are already resistant to all antibiotics except the 
reliable vancomycin. However, over the last few years, vancomycin-resistant strains have 
also emerged (25). Multidrug resistant strains of Mycobacterium tuberculosis, the 
causative agent of tuberculosis - that kills 1.7 million people annually - are also spreading 
all over the world (117). 
How do we overcome the problem of antibiotic resistance? Obviously, increasing 
the direct combative approach may not be a good choice as bacteria may quickly evolve 
to surpass new generations of antibiotics. Even when the use of antibiotics is restricted, 
the incidence of antibiotic resistance is reduced, but never disappears (53, 55). Therefore, 
alternative approaches to prevent the dissemination of antibiotics resistant elements are 
smart choices. 
It has been known that antibiotic resistant bacteria have evolved to acquire many 
mechanisms to resist antibiotics, such as reduction of cell permeability to antibiotics, 
increase efflux of antibiotics, alteration of the antibiotic target site, enzymatic 
inactivation of antibiotics, alteration of metabolic synthesis to bypass the inhibited 
reaction of antibiotics, and overproduction of antibiotic targets (39, 170). These 
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mechanisms can be acquired through spontaneous mutation. However, in the majority of 
cases, acquisition from exogenous sources is the primary mechanism by which bacteria 
obtain genes encoding resistance to antibiotics (39). In these cases, the acquisition of 
genes encoding antibiotic resistance occurs mainly through horizontal gene transfer 
mechanisms: transduction (acquisition from a bacteriophage), transformation (acquisition 
from free DNA from and conjugation (acquisition from another bacterium through a cell-
cell contact). Among these methods, conjugation is by far the most widespread, and most 
efficient. Therefore, a deeper understanding of horizontal gene transfer, especially 
conjugation mechanisms, may help in designing interventions to prevent antibiotic 
resistance dissemination in bacteria. 
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Figure 2: Mechanism of resistance acquisition. DNA encoding an antibiotic resistance 
gene (red) can be transferred by horizontal gene transfer into a recipient by several paths: 
cell-to-cell conjugation; transformation by naked DNA (on plasmids or as linear DNA) 
that is released by dead cells; or phage-mediated transduction. Resistance can also arise 
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by de novo mutation (indicated as a red cross). (Adapted from Andersson et al. Nat Rev 
Microbiol, 2010 (3)). 
 
 
Bacteroides spp, from Commensals to Pathogens 
 
It has been estimated that microbes in our bodies collectively make up to 100 
trillion cells, tenfold the number of human cells (96, 197). Moreover, the number of 
genes in our microbiome is more than 100 times the number of human genes, making us 
genetically 1% human and 99% bacteria (169, 197). The majority of these normal flora, 
with over 500 bacterial species, 1011 organisms per gram of wet weight, reside in the gut, 
have a profound influence on human physiology and nutrition, and are crucial for human 
life (110). Of these, 99% are anaerobes (65). The anaerobic Bacteroides spp. are the most 
predominant species, accounting about 30% of all bacteria in the human gut (149, 189). 
Bacteroides spp. are bile-resistant, non-spore forming, gram-negative, rod-shaped 
anaerobes that are the most predominant bacterial species in the human colon and are less 
abundant in the intestines of other animals and in the environment (161, 192). The genus 
comprises more than 20 species, of which B. fragilis is the most frequent isolate from 
clinical specimens (189).  Bacteroides sp are passed from mother to child during vaginal 
birth and thus become part of the human flora in the earliest stages of life (145). The C+G 
nucleotide composition of Bacteroides genome is in the range of 40-48%. Its membranes 
contain sphingolipids, which is unusual in bacteria. 
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Bacteroides spp. as Gut Commensals 
As part of the human gut normal flora, Bacteroides spp. play a number of 
commensal roles, such as providing energy for the host in the form of short fatty acids 
and sugars, being involved in the recycling of bile acids and aiding in the development of 
the host immune system (189). They also exhibit unique adaptations to successfully 
colonize the gut such as the ability to change their cell surface architecture, ability to 
stimulate host expression of fucosylated glycoproteins and synthesize them, and the 
ability to tolerate and use oxygen. 
Bacteroides spp. provide energy for the host in the form of fatty acids and sugars. 
Bacteroides spp. and other intestinal bacteria ferment carbohydrates to produce a pool of 
volatile fatty acids, predominately acetate, propionate (from succinate), and butyrate, that 
can be easily reabsorbed through the large intestine and utilized by the host as an energy 
source (81). Studies show that germ-free rats lacking gut flora need 30% more calories to 
maintain body mass than normal rats (56). Bacteroides can also generate sugars via their 
glycosylhydrolases; this benefits not just the host but also other organisms that do not 
have such sugar utilization enzymes. B. thetaiotaomicron has an extensive starch 
utilization system and multiple genes (sus genes) that are involved in starch binding and 
utilization (198). B. thetaiotaomicron contains more glycosylhydralases than any 
sequenced prokaryote and appears to be able to cleave most of the glycosidic bonds 
found in nature (197). Encoding 172 glycohydrolases and 163 homologs of starch 
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binding proteins, they can utilize the wide variety of dietary carbohydrates that might be 
available in the gut (196, 198).  
In addition, Bacteroides spp. also play a key role in the recycling of bile acids. 
Before secretion in bile, bile acids are synthesized in the human liver, conjugated to 
taurine or glycine polar side groups. These conjugated forms help bile assist in absorption 
of dietary fats in the upper intestine. If bile acids are not used, they are deconjugated by 
bacteria to re-enter the enterohepatic circulation, return to the liver and re-conjugated for 
further use (15). Containing many enzymes required for these reactions, including a 
hydrolase, dehydrogenase, and dehydroxylase, Bacteroides spp. are known to play a 
major role in the deconjugation of bile acids (116). 
Moreover, during mammalian development, Bacteroides spp. stimulate intestinal 
angiogenesis and induce local and systemic immune function (80, 82, 114). Intestinal 
bacteria are important in the development of gut-associated lymphoid tissue (GALT). 
Without bacterial colonization in the gut, the development of GALT is defective (80). In 
rabbits, B. fragilis and Bacillus substilis promote development of GALT and the pre-
immune antibody repertoire (147). In addition, it has been shown that in newborn mice, 
B. thetaiotaomicron promotes angiogenesis and postnatal development (171). The gut 
epithelium undergoes constant renewal throughout the postnatal period. The appearance 
of Paneth cells, a lineage of stem cells and a key cellular component of the innate 
immune system, coincides with initial colonization of the gut and their subsequent 
differentiation is influenced by the gut microbiota, (6, 20). B. thetaiotaomicron can 
stimulate production of an antimicribial Paneth cell protein (Ang4) that can kill certain 
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pathogens (171). Moreover, zwitterionic polysaccharides (ZPS) produced by B. fragilis 
have been shown to be important in the activation of CD4+ T cells and appear to be 
involved in the development of CD4+ T cells (113). 
As the most predominant bacteria residing in the gut, Bacteroides spp. have 
several unique adaptations allowing them to successfully survive in this niche. They can 
rapidly change their cell surface architecture through the production of an unusually large 
number of phase-variable capsular polysaccharides (87), an adaptation that appears 
specific to the intestinal environment (33). This surface-altering capability is most 
developed in B. fragilis, which is more frequently found at the mucosal surface, the site 
of attack by host defense (88). Also, Bacteroides fragilis has been shown to stimulate 
expression of fucosylated glycoconjugates on the intestinal epithelia of colonized mice 
(21). Bacteroides spp. produce enzymes to harvest fucose from host mucosal glycans and 
have a rare bacterial pathway to incorporate this exogenous fucose directly into capsular 
polysaccharides and glycoproteins (35). It is suggested that the ability of B. fragilis to 
synthesize fucosylated glycoproteins is essential for its competitive colonization in the 
mammalian intestine (32, 35). Finally, the ability of B. fragilis to tolerate and use oxygen 
may partly explain the observation that it is mostly found at the mucosal surface, where 
oxygen tensions are higher than within the intestinal lumen (12).  
 
Bacteroides spp., Commensals Gone Bad Pathogens 
As discussed above, Bacteroides spp. are normally commensals in the gut. 
However, when they escape the gut due to surgery or other trauma, they can cause life-
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threatening infections such as peritonitis and intra-abdominal sepsis (161, 185, 189). 
Intra-abdominal sepsis is the most common infection caused by Bacteroides spp. 
Following the disruption of the intestinal wall due to a surgical wound, malignancies, or 
appendicitis, the gut flora spill out and infect the normally sterile peritoneal cavity. At 
first, the aerobes, such as E. coli, dominate the infection site, reducing the oxidation-
reduction potential of the oxygenated tissue. Once sufficient oxygen has been removed, 
anaerobic Bacteroides spp. replicate and predominate during the second, chronic stage of 
infection (189). Bacteroides spp. rarely cause endocarditis, inflammation of the inner 
layer of the heart, but when it occurs it can be serious with a mortality rate of 21-43% 
(19). They can also be found in other infections such as skin and soft tissue infections, 
bacteremia, septic arthritis, brain abscess and meningitis (189). Enterotoxigenic 
Bacteroides fragilis (ETBF), a sub-group of B. fragilis also has been implicated in 
inflammatory bowel disease (IBD) (10, 140) and colon cancer (176). 
Although B. fragilis accounts for only 1-2% of the human intestinal flora, it is the 
most commonly isolated anaerobic pathogen, partly due to its virulence factors including 
surface polysaccharide capsules, outer membrane vesicles, toxins and β-lactamase (139). 
In addition, the capacity of B. fragilis to tolerate nanomolar concentrations of oxygen 
allows this species to predominate in infections in peritoneal cavity. 
B. fragilis expresses the most number of distinct capsular polysaccharides (at least 
eight). The Bacteroides capsule has an unusual structure, composed of repeating units of 
two distinct high molecular weight polysaccharides, each of which contains exposed 
positively and negatively charged side-chains (179). This zwitterionic motif is critical for 
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promoting the formation of abscesses (179). Injection of capsules alone has proven 
sufficient to induce abscess formation in rats (34). Capsule also can resist to complement-
mediated killing and to phagocytic uptake and killing (54, 146). 
In addition, B. fragilis produces numerous outer membrane vesicles (OMVs). 
These vesicles have been shown to have haemagglutin function and sialidase activity. 
Neuraminidase activity in OMVs was correlated to virulence (42). Moreover, OMVs can 
carry endotoxins to target cells.  
Moreover, B. fragilis may secrete two toxins: endotoxin (LPS) and B. fragilis 
enterotoxin (named BFT or fragilysin). BFT is a 20kD zinc-dependent metalloprotease, 
secreted by enterotoxigenic B. fragilis. ETBF causes acute inflammatory diarrheal 
disease in children and adults (157). BFT mediates proteolytic cleavage of the 
extracellular domain of the adherent protein, E-cadherin, which is a cell-surface protein 
of epithelial cells (195). Higher ETBF colonization levels have also been found in 
individuals with colon cancer relative to others without colon cancer, suggesting that 
EBTF may be involved in development of colon cancer (176). 
Most Bacteroides strains express constitutive β-lactamase activity. β-lactamase 
enzyme is extra-cellular, and thus is capable of diffusing within an abscess or other site of 
infection. Production of extra-cellular β-lactamases has been shown to protect other 
organisms in the vicinity during a mixed infection (129). 
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Figure 3. Proportions of Bacteroides species observed from clinical isolations. 
Adapted from Wexler, Clin Microbiol Rev, 2007. (189).  
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Bacteroides spp. and Antibotic Resistance 
Many Bacteroides spp. are resistant to aminoglycosides (gentamicin, kanamycin, 
streptomycin), tetracycline (nearly 85% of clinical isolates), β-lactam antibiotics 
(penicillin, ampicillin, cephalosporins, cefoxitin, cephamycins and carbapenems), 
metronidazole and the macrolide-lincosamide-streptogramin (MLS) group of antibiotics 
(erythromycin and clindamycin) (161, 192). All of these resistance traits have been found 
on transmissible genetic elements (161). Over the past 3 decades, carriage of the 
tetracycline resistance gene, tetQ, has increased from about 30% to more than 80% in 
clinical strains (161). The fact that these resistance determinants are prevalent and found 
on transmissible elements in Bacteroides spp., particularly conjugative transposons (161), 
is of particular concern. The concern is not only that opportunistic infections caused by 
Bacteroides spp. may become untreatable, but also that Bacteroides spp., as reservoirs of 
antibiotic resistance genes, may then transfer them to other bacterial species. 
The mechanism responsible for the dissemination of genetic elements in 
Bacteroides spp. is conjugation, one of the most important mechanisms of horizontal 
gene transfer in prokaryotes. However, the molecular structure and mechanism of this 
process is poorly understood in Bacteroides spp.  
 
 
Bacterial Conjugation 
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Conjugation, a subset of the bacterial type IV secretion system (T4SS), is defined 
as the unidirectional transfer of single-stranded DNA molecule from a bacterial donor 
cell to a recipient cell, in a process requiring cell-to-cell contact (193). During 
conjugation, one copy of the DNA strand is transferred to, and replicated in, the recipient 
cell. The parent DNA is retained and replicated in the donor cell. Transfer DNA 
molecules, which can be either plasmids or transposons, are of two types: conjugative 
and mobilizable. Conjugative plasmids and transposons are self-transmissible elements. 
They encode all of the components necessary for transfer. Mobilizable plasmids and 
transposons are non-self-transmissible elements. Their transfers require the assistance of 
a co-resident conjugative transfer element. Conjugative elements tend to be large 
(>30kb), while mobilizable elements are small (<15kb) (50). Conjugative plasmids tend 
to have low copy number, while mobilizable plasmids tend to have high copy number 
(50). 
All transfer elements contain a cis-acting origin of transfer (oriT), where transfer 
is initiated. The oriTs are specific sequences, about 30 to 500 bp, significantly located 
adjacent to the transfer initiation genes known as mobilization (“mob”) genes to form a 
compact mobilization region (89). A common feature of the oriT is the presence of 
inverted repeats adjacent to the sequence where nicking of DNA occurs (132). The nick 
(nic) site, a short stretch of about 10 nucleotides is the site for recognition by a relaxase, 
an enzyme required for the nicking of the transfer DNA in the initiation process. 
Conjugation involves two major sets of events: Initiation (DNA processing) and 
conjugal apparatus formation. 
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Initiation (DNA processing) 
DNA processing includes binding, nicking and unwinding of the DNA, 
independent of conjugal apparatus formation (89, 134). This process occurs via the 
relaxosome, a nucleoprotein complex composed of specific proteins (mobilization 
proteins), one of which (relaxase) is covalently linked to the 5’ end of the DNA molecule 
to be transferred (133, 135). The relaxase, the major mobilization protein, nicks the DNA 
to be transferred in a site- and strand- specific manner at its origin of transfer (oriT) (89, 
134), and then covalently associates with the 5’-end of the nicked DNA via a 
phosphotyrosyl linkage. This nicked DNA is unwound and transmitted in single stranded 
copy with 5’-3’ polarity from the donor to the recipient (89).  Single-stranded copies in 
both the donor and the recipient are then re-circularized and made double stranded (89). 
The passage from the donor to the recipient occurs through a specialized membrane 
traversing channel called the conjugal apparatus. 
Relaxase proteins, the major mobilization proteins of the relaxosomes, are large 
and usually contain two or more proteins domains. The relaxase domain is always located 
at the N-terminus of the protein (50). At the C terminus, a DNA helicase, DNA primase 
or other domain of unknown function is almost always found (50). Crystal structures of 
some relaxases have been established, including, the relaxase domain of TraI from F 
plasmid with and without a bound DNA substrate (90, 91), the relaxase domain of TrwC 
from plasmid R388 with bound DNA (13, 66) and the relaxase domain of MobA from 
IncQ plasmid R1162 (121). In many cases, the relaxase domain contains at least three 
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conserved protein motifs. Motifs I contains the active site tyrosine, which creates a 
single-stranded 5’ DNA nick through a trans-esterification reaction similar to type I 
topoisomerase (134). This reaction involves the nucleophilic attack on the DNA-
phosphate backbone by the tyrosine’s hydroxyl group, resulting in a reversible covalent 
phosphodiester bond (23, 89). Motif II might be responsible for the recognition and 
noncovalent binding of the relaxase with the end of the trailing region 3’ of the nic site. 
Motif III is histidine-rich and is called HUH (His-hyrophobic residue-His) or HHH (His-
His-His). This motif may facilitate the cleavage reaction (trans-esterification) by 
abstracting a proton from the terminal tyrosine hydroxyl, allowing the oxygen to act as a 
nucleophile (89). The termination of strand transfer occurs via a second cleavage 
reaction, releasing a single-stranded DNA molecule in the recipient cell (89). 
Most relaxases require assistance from accessory proteins to bend and change the 
conformation of the DNA to facilitate relaxase binding. The RP4 E. coli plasmid encoded 
relaxosome requires three proteins (two cognate proteins and a host encoded integration 
host factor-IHF) for correct conformational DNA bending, which helps the relaxase to 
easily bind and nick the DNA (23). Similarly, relaxase activity of the TrwC relaxase of 
the R388 plasmid system also requires assistance from TrwA (120). In the F plasmid 
system, TraY also enhances the relaxase/helicase activity of TraI (108).  
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Figure 4. Scheme of the relaxase domain of a relaxase. The three conserved motifs are 
represented by red (I), purple (II) or orange (III) boxes.  
 
 
Figure 5. Depicted catalytic activities of a relaxase. (1) The relaxase with relaxase 
domain in blue and helicase domain in red recognizes an extruded cruciform at oriT. (2) 
The binding results in DNA melting and cleavage of the T-strand. (3) The end 3’ to nic 
remains covalently bound to the catalytic tyrosine while the protein moves in the 5’ to 3’ 
direction unwinding the DNA. The uncleaved strand serves as a template for 
complementary strand synthesis (orange) by host DNA polymerase. (4) The relaxase 
reaches the regenerated oriT DNA and again recognizes the specific nic sequence. (5) A 
second cleavage occurs followed by a strand-transfer reaction that (6) produces a 
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circularized T-strand DNA (in blue) that will be transferred to the recipient cell. Adapted 
from Guasch et al., Nature structural biology, 2003 (66). 
 
Conjugal Apparatus 
The second process in conjugation is the formation of the conjugal mating 
apparatus. The conjugal apparatus (CA) is a multi-protein channel that is assembled 
across donor and recipient cell membranes during conjugation for DNA transferring (63, 
154). In addition, there is often a pilus or other surface filament or proteins(s) associated 
with the core complex to facilitate adhesion and contact between two cells (30, 31). 
Although the formation of the conjugal apparatus is well studied in 
Agrobacterium tumefaciens Ti plasmids and E.coli F, RP4 and R388 plasmids, little is 
known about its structure and function in Bacteroides spp. In E. coli and A. tumefaciens, 
this membrane channel is formed by 10-12 proteins (4, 63, 99, 100). In E. coli RP4 
plasmid system, the mating channel is composed of 10 mating pair gene products, a TraF 
pilin support protein and the coupling protein TraG (63, 71). In E. coli F plasmid system, 
that channel is composed of 11 proteins including the coupling protein TraD (93). In A. 
tumefaciens, each of these 12 proteins named VirB1 to VirB11 and VirD4 has been 
extensively characterized (26, 29). Recently, a cryo-electron microsopy (cryo-EM) 
structure of the core complex of the conjugal apparatus encoded by the E. coli 
conjugative plasmid pKM101 showed that the CA complex is 108 Ansgtrom wide and 
high and spans from the inner to outer membranes (48). However, in Bacteroides spp. 
CA in even the best studied element is still poorly understood. To date, the only detailed 
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description of CA-encoding genes in Bacteroides spp. is from the laboratory of Smith 
C.J. et al., who assessed the requirement of each CA gene of the CTn341 isolated from B. 
vulgatus for DNA conjugation by creating deletion mutants (7). 
Studies from T4SS in A. tumefaciens VirB/D4 system suggested four stages 
required for the formation of the CA (30). 
• Stage I: Formation of the core complex. In this stage, a stable structure, termed a 
core complex, composed of several highly conserved proteins, assembles across 
the cell envelope. In A. tumefaciens, the core complex is composed of five highly 
conserved proteins. The existence of this core complex is demonstrated by 
interactions among these proteins (30). There is indirect evidence that this core 
substructure alone confers function. During conjugation between A. tumefaciens 
donor and recipient cells, synthesis of core subunits in the recipient cells 
stimulates acquisition of DNA by several orders of magnitude (14, 102). 
Similarly, in Helicobacter pylori, homologs of A. tumefaciens core complex 
assemble as a competence system (79). 
• Stage II: Recruitment of pilus-associated proteins. In the stage II reaction, the 
core complex recruits subunits required for trans-membrane pilus assembly. In A. 
tumefaciens, the production of the stage II subunits stimulates DNA transfer to a 
greater extent than does synthesis only of the core components (102). 
• Stage III: Recruitment of an ATPase to the inner membrane. It is proposed that 
the ATPase stimulates formation of trans-envelope structures composed of an 
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inner membrane platform, a polymer that extends across the periplasm, and an 
outer membrane pore complex (104). 
• Stage IV: Modifications to yield the pilus or secretion channel. In this stage, the 
pilus may undergo depolymerization to facilitate close cell-to-cell contact. The 
mating apparatus may also undergo conformational changes to become fully 
functional (30). 
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Figure 6. Biogenesis pathway of the A. tumefaciens VirB/D4 T4SS. A four-stage 
assembly pathway is presented. Stage I: assembly of the core complex; Stage II: 
Recruitment of pilus associated components (B2, B3, B5). Stage III: Recruitment of 
ATPase. Stage IV: Formation of T-pilus or DNA secretion channel. Adapted from 
Christie et al., Annu. Rev. Mirobiol., 2005. 
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Table 1. Comparison of conjugal apparatus of different A. tumefacien, E. coli and Bacteroides spp. mating systems. 
Mating system Number of CA proteinsa 
Energetic 
componentsb 
Core channel components Pilus 
components 
Specific for 
own cognate 
relaxosome 
A. tumefaciens 
VirB/D system (2) 
12 
VirD4 (CP), 
VirB11, VirB4 
VirB3, VirB8, VirB10, 
VirB6, VirB7, VirB9, VirB1 
VirB2, VirB5 Yes (73) 
E. coli RP4 
plasmid (63) 
12 TraG (CP) 
TrbB, TrbC, TrbD, TrbE, 
TrbF, TrbG, TrbH, TrbI, TrbJ, 
TrbL 
TraF 
Yes (to closely 
related plasmids) 
(73) 
E. coli F factor 
(93) 
11 TraD (CP), TraC 
TraL, TraE, TraK, TraB, 
TraV, TraG, TraW, TrbC,  
TraA Yes (155) 
B. thetaoimicron 
CTnDOT (161) 
17 putative  
gene products 
Putative CP: TraG 
(OrfG)   
N/A N/A No 
B. fragilis BTF37 
(181) 
N/A.  
Putative CP: BctA 
(77) 
ORF7 (TraM), ORF8 (TraN)c N/A No  
B. vulgatus 
CTn341 (7) 
17 putative  
gene products 
Putative CP: TraG 
(OrfG)  
N/A N/A No 
 
a: Number of CA proteins includes energetic components, core channel components and pilus components.b: Energetic 
components include coupling protein and other ATPase proteins. c. This study.  
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Coupling Protein 
One of the CA’s important components is the coupling protein (CP). CPs are 
present in all conjugative plasmids or transposons. No CP is encoded in any mobilizable 
elements. The CP is unique to conjugation and is considered the first point of contact that 
the relaxosome and/or transfer DNA makes with the CA. The best characterized CPs are 
protein TrwB of plasmid R388 (IncW group), TraD of F plasmids (IncF group), TraG of 
RP4 plasmids (IncP group), and VirD4 of A. tumefaciencs Ti plasmids (61). These 
proteins share the following characteristics: 
1. CPs are not involved in DNA processing events or in pilus production. They are 
needed after pilus assembly and contact formation. For example, traD mutants of 
plasmid F prevent DNA transport to the recipient cell, but not its initiation in the 
donor cell (86). 
2. CPs are composed of transmembrane α-helices in their N-terminal region that 
mediate anchoring to the inner membrane. Indeed, they are integral inner 
membrane proteins (103, 119, 131). They also typically have a main cytoplasmic 
C-terminal domain (38, 63, 94, 103). Thus, their location is the link between a 
cytoplasmic system and the membrane complex CA. 
3. CPs have a nucleotide binding motif, and in fact, can bind both single- and 
double-stranded DNA nonspecifically, suggesting a specific role in DNA transfer 
(119). 
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4. A CP has a Walker box domain (an ATP hydrolysis motif), and some other 
cytoplasmic domains that interact with the relaxosome (141). No ATPase activity 
has been reported so far, but the presence of Walker box motifs suggest that CPs 
use ATP hydrolysis as an energy source to work as motors. It is speculated that 
when CP interacts with the relaxosome, the Walker-box mediates ATP hydrolysis 
to provide energy to “pump” the relaxosome through the CA and into the 
recipient cell (104, 175). With this role, CPs are considered “gatekeepers” of 
conjugation. The A. tumefaciens CA has two of these CP “gatekeepers”, VirD4 
and its required partner VirB4, both of which have nucleotide binding activity 
(44, 115, 141). However, in E. coli, only one CP has been described for each 
conjugative system.  
5. CPs are often multimeric proteins. The 3D crystal structure of the soluble 
cytoplasmic domain of TrwB, the CP of the IncW plasmid R388, shows that it is a 
hexameric protein, resembles a ring helicases (60). 
Most importantly, in many transfer systems, including those elaborated by the E. 
coli F plasmids and A. tumefaciens Ti plasmids, their CPs are highly selective for the 
respective relaxosome to be transferred (73, 155). However, in B. fragilis, the putative 
CPs seem not selective for the relaxosome. Many different conjugative transposons and 
mobile elements even from different origins can be transferred from B. fragilis to bacteria 
from other genus, such as E. coli. This is one reason explaining why Bacteroides spp. are 
considered as reservoirs for transferring antibiotic resistance elements to other bacteria.  
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Figure 7. Conjugation. Conjugation systems represent a large subfamily of the T4SSs 
and are used by bacteria in the process of the conjugative transfer of DNA from donor to 
recipient cells. A) cell-to-cell contact usually by the retraction of the pilus-like structures 
(B). C. ssDNA of the mobile genetic element is transferred from the donor to recipient 
bacteria with the help of the relaxase. D. Complementary DNA strands are synthesized in 
both cells and the former recipient becomes a new potential donor of the mobile DNA. 
Adapted from Juhas et al., Microreview, 2008 (85). 
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Bacteroides spp. Conjugation 
 
Mobile Genetic Elements in Bacteroides 
Bacteroides spp. harbor many conjugative and mobilizable elements, which can 
be transposons or plasmids. A significant proportion of these carries antibiotic resistance 
genes and is critically important in the spead of antibiotic resistance genes. 
 
Table 2: Summary of mobile genetic elements found in Bacteroides spp. 
I. Conjugative elements II. Mobilizable elements 
Self-transmissible Need  help for transfer 
Process DNA for transfer Process DNA for transfer 
Encode mating channel (CA) for completely 
autonomous transfer 
Depend on mating channel formed by 
co-resident conjugative elements 
Many carry many antibiotic resistance genes 
I.a. Conjugative plasmids: II. a. Mobilizable plasmids: 
Have oriT and trans-acting mobilization gene 
Can replicate independently 
Some can integrate into the recipient chromosome 
Examples: pBF4 (159), pBI136 (164) Examples: pBTM10 (168) 
I. b. Conjugative transposons: II. b. Mobilizable transposons: 
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Located on chromosome 
Do not replicate independently 
52 kb to 150 kb Much smaller 
Are referred to as Tet elements since most 
of them carry the tetracycline resistance 
gene tetQ. 
 
Examples: BTF-37 (181), CTnDOT (16), 
CTnERL (17), Tcr Emr DOT (97), Tcr Emr 
7853 (127), CTnBST (70), CTnGERM1 
(184), CTn86 (22) and CTn9343 (22). 
Examples: Tn4399 (78), Tn5520 
(183), cLV25 (9), NBU1, NBU2 
(98), Tn4555 (166) 
 
Plasmids. Plasmids are very common in Bacteroides spp. and are found in 20 to 
50% of strains (189). Almost all plasmids can replicate as independent elements in host 
cells, and some can integrate into the host chromosome (153). Many plasmids have oriT 
and a trans-acting mobilization gene, which allow them to be transferred by conjugation 
(189). 
Genes resistant to many antibiotics have been found in plasmids in Bacteroides 
spp. Genes resistant to metronidazole, chloramphenicol, carbapnems, clindamycin and 
erythromycin have been found in mobile plasmids in Bacteroides spp. worldwide. 
Resistance genes nimA -  nimF, encode metronidazole resistance, have been identified on 
transferrable plasmids and observed in several cases worldwide (106). The cfiA gene, 
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conferring resistance to carbapenems, has also been found on a plasmid in clinical 
isolates (124). 
To date, two conjugative plasmids have been identified: the B. fragilis 41 kb 
pBF4 plasmid and B. ovatus 80.6 kb pBI136 plasmid. Sequence analysis of the transfer 
regions of these plasmids have been limited due to A-T rich sequence properties. Only 
one gene, bctA, encoding a putative 110 kD protein that localizes to the membrane, has 
been characterized as being required in mating process (123). There are also other 
mobilizable plasmids that can only be transferred via mating channel formed by other co-
residant conjugative elements, such as B. fragilis BFTM10 (168). 
 
Transposons. Transposons, both mobilizable and conjugative, are located on the 
chromosome and do not replicate independently. They excise from and integrate into 
chromosomal DNA and are copied along with the chromosomal DNA. 
Mobilizable transposons, like mobilizable plasmids, cannot self-transfer but can 
transfer from bacterium to bacterium in the presence of the helper element (189). 
Mobilizable transposons are much smaller than conjugative transposons and carry genes 
required for excision, mobilization and integration. However, they do not encode the 
conjugal apparatus components and have to rely their transfer on other co-resident 
conjugal elements like conjugative transposons. Some identified mobilizable transposons 
are B. fragilis 3.9 kb Tn4399 (78), B. fragilis 4.69 kb Tn5520 (183),  B. fragilis 15.3 kb 
cLV25 (9), B. uniformis 10.3 kb NBU1, B. uniformis 11.1 kb NBU2 (98) and B. vulgatus 
12.5 kb Tn4555 (166). 
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Conjugative transposons (CTn) are frequently found in Bacteroides spp. More 
than 80% of Bacteroides strains contain at least one conjugative transposon (161). 
Several conjugative transposons or tetracycline resistance factor (Tcr) ranging from 52 kb 
to 150 kb have been identified in Bacteroides spp., including B. fragilis BTF-37 (37 kb) 
(181), B. thetaiotaomicron CTnDOT (65 kb) (16), B. thetaiotaomicron CTnERL (52 kb) 
(17), B. thetaiotaomicron Tcr Emr DOT (70 kb) (97), B. thetaiotaomicron Tcr Emr 7853 
(70 kb) (127), B. thetaiotaomicron CTnBST (100 kb) (70), B. thetaiotaomicron 
CTnGERM1 (75 kb) (184), B. vulgatus CTn341 (52 kb) (7), B. fragilis CTn86 (57 kb) 
(22) and B. fragilis CTn9343 (64 kb) (22). Of these, CTnDOT (65 kb) from B. 
thetaiotaomicron is the best described. CTns are also referred to as Tet elements since 
most, but not all, carry the tetracycline resistance gene tetQ (153, 158). Tet elements also 
carry the rteABC gene cluster involved in the regulation of Tet element conjugal transfer 
(160, 173). rteA and rteB genes encode a tetracycline inducible two-component 
regulatory system, which controls rteC expression (173). As a result, very low (sub 
inhibitory) levels of tetracycline or its analogs with brief exposures can markedly elevate 
conjugal transfer of Tet elements and other co-resident factors 1,000-to 10,000-fold (144, 
160). Many B. fragilis conjugative transposons also carry erythromycin resistance genes 
such as ermF (CTnDOT) (190), ermB (CTnBST) (188) or ermG (CTnGERM1) (184). 
Conjugative transposons are mainly responsible for the spread of tetracycline and 
erythromycin resistance in clinical isolates of Bacteroides spp (161). They are not only 
responsible for the transfer of antibiotic resistance genes on itself but also for the transfer 
of antibiotic resistance genes on other mobilizable elements. They are able to stimulate 
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the excision and transfer of mobilizable transposons. The exact mechanism by which 
conjugative transposons stimulate the excision and transfer of mobilizable transposons is 
unknown. However, it is known that RteA and RteB encoded by genes located within the 
central regulatory region of the CTnDOT/ERL family of conjugative transposons are 
essential for the excision and mobilization of the NBUs mobilizable plasmids (172). 
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Figure 8: Steps involved in the conjugal transfer of a conjugative transposon (192). 
The integrated conjugative transposon (rectangle) excises from the chromosome of the 
donor to form a covalently closed circular transfer intermediate in which the left and right 
ends of the conjugative transposons are joined. A single-stranded nick is subsequently 
made at the origin of transfer (oriT, black circle) in the circular intermediate, and the 
nicked strand is presumably to be transferred from donor to recipient by a process similar 
to conjugal transfer of plasmid DNA. In the donor and recipient, the single-stranded copy 
of the conjugative transposon is replicated, yielding a double-stranded form of the 
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conjugative transposon which then integrates in the donor and recipient chromosomes, 
respectively. Adapted from Whittle et al., Cell Mol Life Sci, 2002. 
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B. fragilis LV23, Conjugative Transposon BTF-37, Putative Coupling Protein 
BctA and the Relaxase BmpH 
Previously, our laboratory reported the capture of BTF-37, a 37kb conjugative 
transposon, from a clinical B. fragilis isolate, LV23 (181). BTF-37 alone is capable of 
facilitating transfer of DNA not only within the Bacteroides, but also from B. fragilis to 
E. coli (181). Due to A-T rich regions, only 16kb of BTF-37 was sequenced. This 16kb 
region carries 11 ORFs. By sequence homology analysis with other known Bacteroides 
transfer factors, and by RT-PCT studies, these 11 genes likely correspond to the transfer 
region of BTF-37 (77). Of these 11 ORFs, bctA is an ORF highly conserved between 
different Bacteroides transposons. 
bctA encodes a putative coupling protein of BTF-37 CTn (77). It is identical to the 
putative coupling protein BctA of B. fragilis conjugative plasmid pBF4, 98% identical to 
that of the B. fragilis NCTC9343, 74% to the B. fragilis YCH46 strain from Japan, and 
48% to a BctA homolog from the B. fragilis CTnDOT conjugative transposon (77). 
Computer analysis also reveals that BctA has two Walker-box-sequences as a 
characteristic of a coupling protein. We also showed that BctA is a conjugal apparatus 
protein required for transfer of BTF-37 (77). It has signal sequence required for 
membrane localization, its expression is upregulated under conjugation conditions and 
purified BctA migrated as a tetramer under non-denaturing PAGE. 
BmpH is a relaxase encoded by the 4.6 kb mobilizable transposon Tn5520 that 
was also isolated from B. fragilis clinical isolate LV23 (182, 183). Tn5520 carries only 
two genes, that encode an integrase (bipH) and a mobilization protein (bmpH) 
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respectively. Studies from our laboratory have shown that BmpH is a relaxase protein 
that is required for the formation and function of the relaxosome, required for the 
mobility of Tn5520 (182).  BmpH alone is sufficient and required for DNA transfer of 
Tn5520. It has been shown to be multifunctional, performing the specific recognition, 
binding, and nicking of the oriT DNA (182). 
 
 
The Search for Better Genetic Modification Tools in Anaerobes 
 
To investigate protein function in a bacterial strain, it is important to generate a 
knock-out (KO) strain to determine if a target protein is unable to perform a predicted 
function. In B. fragilis and many other anaerobes like Clostridium spp., a traditional 
method is to use a suicide vector to deliver a disrupted construct of the target gene from 
E. coli to the recipient strain (32, 36). This method is based on integration of the altered 
construct into the chromosome followed by screening for spontaneous resolution of the 
diploid to yield the desired product (deletion of the target gene in the chromosome). 
However, this method is time-consuming and problematic due to stringent recombination 
barriers encountered in these genera (150). An alternative approach uses resistance to 
trimethoprim, encoded by a chromosomal thyA mutation in B. fragilis, to select for 
resolution of diploids where the suicide plasmid carries a functional copy of thyA (11). 
Although this method helps resolve diploids, the strain to be engineered must be made 
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trimethoprim resistant and all resulting strains contain a thyA mutation, which may have 
undesirable consequences for further studies. 
A recent study shows a new approach to delete a target gene in B. fragilis NCTC 
9343 by using the I-SceI meganuclease to mediate double strand breakage, allowing 
resolution of diploid (137). In essence, a suicide plasmid (pEP185.2), containing an I-
SceI recognition site, and sequences homologous to chromosomal DNA flanking an ermF 
cassette and replacing the gene to be deleted is introduced into B. fragilis by conjugation, 
and transconjugations are selected for resistance to erythromycin (137). Then, another 
plasmid expressing I-SceI enzyme under the control of the fucose-inducible promoter 
PfucR is transformed into the B. fragilis transconjugant. Under inducible condition, I-SceI 
is expressed, induces breakage of double strand DNA at the I-SceI recognition site, 
allowing resolution of the diploid to generate either the deletion or wild-type genotypes 
by homologous recombination. However, this method has its own drawbacks. First, 
it requires transformation to introduce the plasmid expressing I-SceI into B. fragilis cells, 
which is known to be difficult to work with. Second, the suicide plasmid pEP185.2 is 
tetracycline and erythromycin resistant, which is not useful for the selection of this 
plasmid in clinical strains already tetracycline and erythromycin resistant like LV23. 
Moreover, the presence of ermF in the suicide vector may allow plasmid incorporation 
into ermF in the B. fragilis chromosome, not into the desired target gene.  
Although not widely investigated in prokaryotic systems, antisense RNA 
(asRNA) is a potent and flexible tool for manipulating microbial genetic. AsRNAs have 
been successfully used to suppress the expression of bacterial proteins in several studies, 
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especially in the clostridia (118, 125, 138, 143, 177, 178), where very similar difficulties 
are encountered in generating knock-out mutants. Thus, although not has been tested in 
B. fragilis this approach seems to be applicable in B. fragilis studies. 
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CHAPTER III 
MATERIALS AND EXPERIMENTAL METHODS 
 
 
Chemicals and Reagents 
 
Chemicals and reagents used in this study were purchased from Sigma-Aldrich, 
Inc. (St. Louis, MO), Fisher Scientific (Pittsburgh, PA) and Thermo Scientific (Waltham, 
MA) unless otherwise mentioned. 
  
Bacterial Strains and Plasmids 
Bacterial Strains and plasmids used in this study are listed in Table 3 and 4. 
 
Table 3. Bacterial strains used in this study 
Strain  Relevant characteristic(s)a Source or Reference 
E. coli HB101 SmR (18), Invitrogen 
E. coli DH5α recA1, endA1 (64), Invitrogen 
E. coli XL-1Blue recA1, endA1, KnR Agilent Technologies  
E. coli XL-1Blue MRF TcR, Δ(mcrA)183 Δ(mcrCB- Agilent Technologies  
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hsdSMR-mrr)173 endA1 supE44 
thi-1 recA1 
Bacteriomatch II 
Reporter Cells 
KnR Agilent Technologies  
Bacteriomatch II 
Validation Reporter 
Competent Cells 
KnR Agilent Technologies  
E. coli BL-21AI araB::T7RNAP, TcR Invitrogen 
B. fragilis LV23 TcR Clinical isolate 
B. fragilis TM4000 RfR (163) 
B. fragilis TM4000 
BTF-37 
 Hecht’s laboratory 
a: SmR, KnR, TcR, RfR indicate resistance to streptomycin, kanamycin, tetracycline and 
rifampicin, respectively. 
 
Table 4. Plasmids used in this study 
 
Plasmid Relevant characteristic(s)a Source or Reference 
BTF37 ApR ClnR TetXRTetR, ≈37-kb insert 
in pGAT400ΔBglII 
(181) 
pGAT400ΔBglII ApR ClnR TetXR (76) 
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RK231 KmR, E. coli broad-host-range R 
plasmid 
(68) 
pQE30Xa Protein expression vector with 6 
Histidine tag and Factor XA 
cleavage site, AmpR 
Qiagen 
pA8-Xa Truncated bctA (lacking signal 
sequence) cloned in pQE30Xa 
(77) 
p17-Xa Full-length bmpH cloned in 
pQE30Xa 
(77) 
pDEST42 Expression vector, Histidine and 
V5 C terminal tag, AmpR 
Invitrogen 
p42M Full-length traM cloned in 
pDEST42 
This study 
pDEST24 Expression vector, Glutathione-S-
transferase C terminal tag, AmpR 
Invitrogen 
p24M Full-length traM cloned in 
pDEST24 
This study 
p24bmpH Full-length bmpH cloned in 
pDEST24 
S. Kralicek’s work in 
the Hecht laboratory 
pFD351 Shuttle vector, ErmR, SpR, CcR 
(Bacteroides sp.) 
(136) 
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pFD288 Shuttle vector, ErmR (CcR in B. 
fragilis), SpR, (Bacteroides sp.) 
(167) 
pFD288P PcfxA cloned in pFD288 This study 
pFD288MAS1 traM-antisense AS1 cloned in 
pFD288P 
This study 
pFD288MAS2 traM-antisense AS2 cloned in 
pFD288P 
This study 
pFD288MAS3 traM-antisense AS3 cloned in 
pFD288P 
This study 
pBT Bait vector for bacterial two hybrid 
experiment 
Agilent Technologies  
pTRG Target vector for bacterial two 
hybrid experiment 
Agilent Technologies  
pBT-LGF2 Positive control bait vector for 
bacterial two hybrid experiment 
Agilent Technologies  
pTRG-Gal11 Positive control target vector for 
bacterial two hybrid experiment 
Agilent Technologies  
pBT-M  (pBT-ORF7) Full-length traM cloned in bait 
vector, pBT 
This study 
pBT-BctA Full-length bctA cloned in bait 
vector, pBT 
This study 
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pBT-BmpH Full-length bmpH cloned in bait 
vector, pBT 
This study 
pBT-ORF5 Full-length orf5 cloned in bait 
vector, pBT 
This study 
pBT-ORF6 Full-length orf6 cloned in bait 
vector, pBT 
This study 
pBT-ORF8 Full-length orf8 cloned in bait 
vector, pBT 
This study 
pBT-M-F66A traM mutation F66A in pBT vector This study 
pBT-M-F66G traM mutation F66G in pBT vector This study 
pBT-M-F66R traM mutation F66R in pBT vector This study 
pBT-M-L69A traM mutation L69A in pBT vector This study 
pBT-M-L69G traM mutation L69G in pBT vector This study 
pBT-M-L69R traM mutation L69R in pBT vector This study 
pBT-M-L123A traM mutation L123A in pBT 
vector 
This study 
pBT-M-L123G traM mutation L123G in pBT 
vector 
This study 
pBT-M-L123S traM mutation L123S in pBT 
vector 
This study 
pBT-M-L123R traM mutation M123R in pBT This study 
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vector 
pBT-M-M154A traM mutation M154A in pBT 
vector 
This study 
pBT-M-M154G traM mutation M154G in pBT 
vector 
This study 
pBT-M-M154R traM mutation M154R in pBT 
vector 
This study 
pBT-M-M154C traM mutation M154C in pBT 
vector 
This study 
pTRG-M Full-length traM cloned in target 
vector, pTRG 
This study 
pTRG-BctA Full-length bctA cloned in target 
vector, pTRG 
This study 
pTRG-BmpH Full-length bmpH cloned in target 
vector, pTRG 
This study 
pTRG-L123S traM mutation L123S in pTRG 
vector 
This study 
pTRG-M154C traM mutation M154C in pTRG 
vector 
This study 
pBT-BctAtrunc Truncated bctA, lacking the N-
terminal signaling sequence (32 
This study 
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amino acids), in pBT vector. 
pTRG-BctAtrunc Truncated bctA, lacking the N-
terminal signaling sequence (32 
amino acids), in pTRG vector. 
This study 
pBT-TraG TraG of E. coli RP4 plasmid in 
pTRG vector 
This study 
pBT-TetQ B. fragilis LV23 tetQ in pBT vector This study 
pTRG-TetQ B. fragilis LV23 tetQ in pTRG 
vector 
This study 
 
Bacterial Media, Growth Conditions and Optical Density Readings  
 
Escherichia coli cells were grown in Luria-Bertani (LB) medium (1% w/v 
tryptone (Sigma), 0.5% w/v yeast extract (Sigma), 1% sodium chloride). Bacteroides spp. 
were grown in BHIS medium (3.7% brain heart infusion medium supplemented with 
0.0005% hemin and 5 g of yeast extract/liter) in a Coy anaerobic chamber (5% CO2, 10% 
H2, and 85% N2). Agar (Difco) was added to broth at 1.5% (w/v) for plating. Media were 
sterilized by autoclaving for 30 mins at 15 pounds per square inch prior to addition of 
antibiotics. 
E. coli growth was measured using a Spectronic Genesys 10UV 
Spectrophotometer (Thermo Scientific Inc., Waltham, MA) by taking absorbance 
readings at a wavelength of 600nm. B. fragilis growth was measured at a reading 
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wavelength of 660mn. 1 ml of bacterial culture was measured and compared to cell free 
medium as the blank in disposable platic cuvettes (VWR, West Chester, PA). 
 
 
Antibiotics 
 
All antibiotics were supplied by Sigma-Aldrich, Inc. Antibiotic concentrations 
used for the selection of strains and plasmids included the following: ampicillin, 200 
μg/ml; clindamycin, 12 μg/ml; streptomycin, 50 μg/ml; spectinomycin, 50 μg/ml; 
rifampin, 25 μg/ml; kanamycin, 25 μg/ml; gentamicin 25 μg/ml; tetracycline, 13.5 (for E. 
coli) or 5 μg/ml (for Bacteroides spp.). 
Antibiotic stocks were prepared at 10X concentrations and stored in 1 ml aliquots 
at -200C. Ampicillin, spectinomycin, streptomycin or clindamycin powder was dissolved 
in Milli-Q ultrapure water (Milipore Co.) by vortexing. Chloramphenicol was dissolved 
in 100% ethanol by vortexing. Tetracycline was dissolved in 50% ethanol (v/v) by 
vortexing. All antibiotics were filtered sterilized through 0.25 μm syringe filters (Pall 
Corporation, East Hill, NY) attached to 5 ml syringes. 
 
 
Recombinant DNA Techniques. 
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Plasmid DNA was prepared by affinity purification (Qiagen, Chatsworth, CA). 
Restriction endonucleases and DNA ligase were purchased from New England Biolabs 
(Beverly, MA). PCR was performed using a commercially available kit that contained the 
Amplitaq-Gold DNA polymerase (Applied Biosystems, Foster City, CA). DNA 
sequencing was performed using an ABI377 sequencer at the DNA sequencing facility of 
the University of Florida, Gainesville, FL.  
 
 
B. fragilis Genomic DNA Preparation 
 
B. fragilis genomic DNA was purified from 5 ml overnight cultures by using 
DNeasy Blood and Tissue Kit (Qiagen) according to the manufacturer’s instructions with 
some modifications. Briefly, 5 ml of overnight culture was harvested and centrifuged at 
7, 500 rpm for 10 mins. Cell pellets were then resuspended in 900 μl ATL lysis buffer. 
100 μl of proteinase K was added to the lysis and mixed by vortexing. Lysis was then 
incubated at 550C for 15 mins with vortexing occasionally during incubation and was 
vortexed for 15 secs. 1 ml of AL buffer was added to the sample with vortex, incubated 
for 10 mins at 700C. Then, 1 ml of HPLC purified Ethanol (Sigma) was added and 
vortexed, and the lysate added to a DNeasy Mini Spin column, centrifuged at 8,000 rpm 
for 1 min to discard flow through, and then harvested in new 2 ml collection tubes. 500 μl 
of the first wash solution AW1 was then added, and the column centrifuged for 1 min at 
8,000 rpm. The column was then placed in another new 2 ml collection tube, 500 μl of 
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the second wash solution AW2 added, and centrifuged for 3 mins at 14,000 rpm to dry 
the DNeasy membrane. The column was then placed in a clear 1.5 ml microcentrifuge 
tube, 200 μl of elution buffer AE added, incubated at room temperature for 1 min, and 
centrifuged for 1 min at 8,000 rpm to elute.  
 
 
B. fragilis RNA Purification, RT-PCR and Quantitative PCR 
 
B. fragilis overnight cultures were sub-cultured in pre-reduced BHIS liquid media 
under anaerobic conditions from an overnight (ON) culture with the ratio of 1/50. When 
the OD660 = 1.2 (about 1.5 hrs after culture), the culture was stimulated with tetracycline 
to a final concentration of 1 μg/ ml. About 4 hrs after tetracycline induction, when 
bacteria reached mid-exponential phase, OD660 = 0.6, 0.5 ml of each culture was collected 
for RNA purification. 
RNA for RT-PCR was purified using Qiagen RNeasy mini kit and protocol. For 
RT-PCR of BTF-37 11 ORFs, Biorad RT-PCR kit was used for RT-PCR reactions. The 
RNA was tested for DNA contamination by checking RT-PCR products from reactions 
with or without reverse transcriptase. The transcript production from each of 11 ORFs 
was investigated by RT-PCR with specific primers from 250 ng purified RNA. RT-PCR 
from 16S was used as the control and for normalization. RT-PCR from tetQ was used as a 
positive control. RT parameters: 250C: 5 min, 420C: 30 min, 850C: 5 min. cDNA was 
diluted to 1:5 then diluted DNA was used for PCR reaction. PCR parameters: 950C: 5 
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min, 25 cycles of (950C: 15sec, 510C: 30sec, 700C: 30sec), 720C: 7 min. RT-PCR 
products were examined on 1% agarose gels. The concentration of DNA was measured 
by densitometry in an imaging system FluochemTM 8900, Alpha Innotech, and was 
normalized according to the density of 16S rDNA transcripts. 
RNA for Q-PCR was purified using Ambion MICROBExpress™ Bacterial 
mRNA Enrichment Kit (Applied Biosystem, Carlsbad, CA), following the manufacturer 
instructions. However, due to easy contamination of DNA in the B. fragilis RNA 
samples, RNA containing columns were digested three times with DNAse before elution 
to collect pure RNA. The RNA was tested for DNA contamination by checking on 
agarose gel RT-PCR products from reactions with or without reverse transcriptase. 
Quantitative PCR reactions were performed using SYBR labeling technique, 
using 5 Prime reagent kits (5 Prime, Gaithersburg, MD) and Eppendorf Realplex Q-PCR 
(Eppendorf, Hamburg, Germany) machine. 
Q-PCR data was analyzed using the ΔΔCt method (77): 
E = Efficiency; ref =  reference gene; gene = test gene  
Relative expression = (E gene) x ΔCt gene (Tc--Tc+) 
Adjusted relative expression (REadj) = RE (unkown) x 1/RE (ref). 
Reference gene: 16S rDNA for expression of tram in B. fragilis LV23 with or without 
conjugation condition induction; tetQ for expression of tram in B. fragilis LV23 strains in 
the presence of different antisense constructs. 
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Table 5. Primers used for RT-PCR and Q-PCR 
Primers Sequence 
ORF1 Fwd TTG CTT TGC ACC ATG ATT TT 
 
ORF1 Rev GGG CGT GAA GAA CTT GTA GC 
 
ORF2 Fwd GCC AAT GAA GCA AAA ATT CC 
 
ORF2 Rev TGC ATA TTG CGA GAA GGT G 
 
ORF4 Fwd TTG TCG GGA CAG ATG TAA ACC 
 
ORF4 Rev CCC CGG AGC TAA TGT TTG TA 
 
ORF5 Fwd TAT CCC GTT ATT GCG TCC AT 
 
ORF5 Rev ATA GCC TTG CTT CGT GCT GT 
ORF6 Fwd GCG AGT TCT GCA ACA GTA ACA 
 
ORF6 Rev TTT TCA GTG CGT GGA ATT TG 
 
ORF7 Fwd CGA AAA ATC CCG CAG AAG TA 
 
ORF7 Rev ATG CGT ACT CGG CTA CCA TC 
 
ORF8 Fwd GCA GGT GAA AAC CCA GAA GA 
 
ORF8 Rev CCA GTA GGA ATA TCG CCA ACA 
 
ORF9 Fwd ATT TCA GGA GGT TGG CAA TG 
 
ORF9 Rev GCA CCT ATG CCG AAT GTT TT 
 
ORF10 Fwd TGC CGC AAT AAT GAA CTT TG 
 
ORF10 Rev AAG TGC GTT CCT CCA ATG AT 
 
ORF11 Fwd AGA GCA GCA GCA GTA GGA AA 
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ORF11 Rev TTT TAG CAC GTC CAG CTT CA 
 
16S 1F GGG GTT CTG AGA GGA AGG TC 
16S 1R CTT CGC AAT CGG AGT TCT TC 
TetQ-1369F ATC GTC GTC ATG GTT GCA TA 
TetQ-1527R GGT GTG AAT TTG GAG CGT TT 
 
 
Measuring DNA and RNA Concentration 
 
DNA and RNA concentrations were measured using a NanoDrop 1000 
Spectrophotometer (Thermo Scientific).  
 
 
Preparation of Competent E. coli cells and Transformations 
 
Preparation and storage of competent E. coli cells to be used for transformation 
was adapted as described previously (128). A fresh, single colony of E. coli cells was 
grown in 5 ml of LB media overnight. 500 μl of the overnight culture was diluted 1: 100 
in 50 ml of competent cell growth media (LB medium supplemented with 10 mM 
magnesium sulfate (Mg2SO4) and 0.2% (w/v) glucose). Cells were grown to mid-log 
phase to an optical density reading of about 0.6 at wavelength of 600nm. Cells were then 
incubated on ice for 10 mins, and centrifuged at 3000 rpm for 10 mins at 40C in the 
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Beckman Allegra X-15R bench top centrifuge to pellet the cells. Cell pellets were then 
resuspended in 500 μl of cold competent cell growth media. 2.5 ml of cold competent cell 
storage (LB medium supplemented with 36% glycerol, 12% (w/v) polyethylene glycol 
(PEG) and 12 mM Mg2SO4) was added to the cells. 200 μl aliquots of cells were 
transferred into pre-chilled microcentrifuge tubes and stored at -800C. 
Ligation reactions of a sub-cloning procedure or plasmids or a mixture of 
plasmids for a bacterial two hybrid experiment were introduced into E. coli competent 
cells by transformation. A desired amount of DNA (10 ng of plasmid, or 20 μl of a 
ligation reaction, or a mixture of 50 μg DNA of both the bait and the target plasmids in a 
bacteria two hybrid experiment) were pipetted into a polypropylene tube and chilled on 
ice. 100 μl of competent cells were thawed on ice and transferred to the tube with DNA. 
The cells were incubated with the DNA on ice for 30 mins, heat shocked at 420C for 30 
secs and then chilled on ice for 2 mins. 900 μl of LB medium was added to the cells and 
they were grown at 370C shaking at 250 rpm for 1 h. 100 μl of the transformation culture 
was plated onto a selective medium plate. The remaining 900 μl of cells were centrifuged 
at 3500 rpm for 5 mins in the Beckman centrifuge. The pellet was gently resuspended in 
100 ml of LB medium and plated onto selective medium plate. Plates were incubated at 
370C overnight to promote colony growth. 
Special growth conditions were applied for transformations for bacterial two 
hybrid assays. This is described in the bacterial two hybrid assay section. 
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Non-denaturing Protein Purifications 
 
To prepare for Far-Western experiments, non-denatured BctA and BmpH proteins 
were purified from pA8-Xa and p17Xa expression vectors, respectively, in XL1-Blue 
cells. Briefly, 25 ml of LB medium was inoculated with 500 μl of overnight culture cells 
of XL1-Blue pA8-Xa or XL1-Blue p17Xa, and grown at 370C with shaking at 250 rpm. 
For induction of BctA from pA8Xa expression vector in XL1-Blue cells, 1 mM final 
concentration of IPTG was added to the culture at mid-logarithmic phase (OD600nm=0.5). 
For induction of BmpH from pDEST42BmpH vector, a 0.2% (w/v) final concentration of 
L-arabinose was added to the culture at mid-logarithmic phase. After induction, cell 
cultures were incubated at 300C, overnight with shaking. After incubation, cells were 
harvested by centrifugation at 3500 rpm for 30 min by using a Beckman Coulter Allegra 
X-15R bench top centrifuge. Cell pellets were then frozen overnight at -200C. After being 
thawed, cell pellets were resuspended in 15 ml native lysis buffer (50 mM NaH2PO4, 
300 mM NaCl, 1.5% Tween-20, pH 7.5), added 600 μl of proteinase inhibitor cocktail 
(Roche, Indianapolis, IN). The cell suspension was gently rocked at room temperature for 
2 hrs and then sonicated on ice at 55% for 6 x 30 secs pulse with 30 secs rest in between). 
Lysates were cleared by centrifugation at 2850 g, 40C for 30 mins and then applied to 
TALON cobalt affinity column (Clontech, Mountain View, CA) pre-equilibrated with 2 x 
1 ml lysis buffer and 1 x 0.5 ml lysis buffer plus 0.5 ml wash buffer (50 mM NaH2PO4, 
300 mM NaCl, and 15 mM imidazole, pH 7.5). Columns were then washed 3 x 1 ml of 
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wash buffer. Immobilized His-tagged proteins were eluted in 3 x 550 μl fractions (50 mM 
NaH2PO4, 300 mM NaCl, and 200 mM imidazole, pH 7.5) 
Protein Preparation from B. fragilis Cultures 
 
To collect proteins from B. fragilis cultures, overnight cultures were subcultured 
in 1: 50 dilution to 45ml of pre-reduced BHIS medium, grown anaerobically at 370C until 
mid-logarithm phase (OD660nm=0.5). Cells were then harvested by centrifugation at 3500 
rpm, 40C for 30 mins in a Beckman Allegra X-15R centrifuge. Pellets were then 
resuspended in 3.5 ml PBS, protease inhibitor added (Roche, Indianapolis, IN), sonicated 
for 4x 15 secs with 15 secs rest in between at 45% power, then centrifuged at 11,000 rpm, 
40C for 1 hr using Beckman Coulter TLA 100 Ultracentrifuge with a TLA100.3 rotor. 
Supernates containing total proteins were collected and stored at -200C overnight. The 
next day, supernates were thawed on ice, centrifuged at 70,000 rpm, 40C, for 2 hrs using 
Beckman Coulter TLA 100 Ultracentrifuge with a TLA100.3 rotor, and cytoplasmic 
proteins collected from supernatant liquids. Pellets were washed with 3 ml PBS and 
centrifuge at 70,000 rpm, 40C, for 2 hrs, after which, those supernatant fluids were 
discarded. Pellets containing membrane proteins were resuspended in 600 μl PBS, 
sonicated 4x 15 secs with 15 second rest in between, at 45%. 
 
 
Protein Quantification 
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In most cases, the concentrations of total proteins was measured using the 
Bicinchoninic Acid (BCA)TM Protein Assay Kit (Pierce), according to the manufacturer’s 
instructions. A series of dilutions of known concentration of bovine serum albumin 
(BSA) was prepared and assayed together with the unknown protein and then the protein 
concentration of the each unknown sample was determined in μg/ml based on the 
standard curve. 
Purified His-BctA, His-BmpH and TraM-His in elution buffer containing 200 
mM imidazole were quantified by Coomassie Plus the Better Bradford Kit (Pierce, 
Rockford, IL).  
 
 
Agarose Gel Electrophoresis 
 
The DNA or PCR products were separated by agarose gel electrophoresis with an 
agarose concentration of about 1%. The agarose (Sigma-Aldrich) gel was prepared in 1X 
TAE buffer (40 mM Tris-acatate, 1 mM EDTA). After the gel was run for a required 
time, the DNA was visualized by staining the gel with 0.5 μg/ml of ethidium bromide and 
images were taken using AlphaImager automated CCD camera, AlphaInnotech- Cell 
Biosciences, San Leandro, CA. 
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Polyacrylamide Gel Electrophoresis 
 
Proteins samples were boiled in Laemmli sample buffer (BioRad, Hercules, CA) 
containing 5% β-mercaptoethanol in a 1:1 ratio for 10 mins. Samples were then loaded 
on Tris-CL polyacrylamide gel in 1 x TGS (2.5 mM Tris-Cl, 19.2 mM Clycine, 0.01% 
SDS) (BioRad, Hercules, CA). Electrophoresis was carried out at constant 200 volts for 
various times depending on the gel percentage. 
Gels were washed for 10 secs in dIH2O and then stained with GelCode Blue Stain 
reagent (Thermo Scientific Inc., Waltham, MA) for 60 mins, and destained with dIH2O. 
 
 
Immunoblot Experiments 
 
Proteins were visualized by western blotting as described previously (199). 
Electrophoresis was performed as stated above and gel contents transferred overnight 
onto 0.45 μM nitrocellulose membrane at 50 volts in 1 x TG buffer (2.5 mM Tris-Cl, 
19.2% Glycine) at 40C with stirring in a Trans-Blot cell (BioRad, Hercules, CA). For 
primary antibodies lacking the horse-radish peroxidase label, blots were developed using 
a Roche Western Blotting Kit (Roche, Indianapolis, IN). In short, blots were blocked 
with shaking for at least 80 mins at room temperature or overnight at 40C, using 1% 
blocker in 1X TBS and then incubated for 60 mins with primary antibodies in 0.5% 
blocker in TBS, at room temperature. Anti-λcI antibodies and anti-TraM antibodies were 
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used at the dilution of 1: 1,000 and 1: 200, respectively. Blots were then washed 3 x 10 
mins with TBST (50 mM Tris-Cl, 150 mM NaCl, pH 7.5 and 0.1% Tween 20). Then, 
blots were incubated for 30 mins with secondary antibodies, anti rabit and anti mouse 
IgG antibodies, washed 4 x 15 mins with TBST. Blots were developed for 1 min using a 
mixture of 1 part solution A and 100-1000 part solution B, and exposed to CL-XPosure 
film (Pierce, Rockfort, IL). 
When using horse-radish peroxidase-labeled (HRP) antibodies like RGS-His and 
6x His antibodies (Qiagen, Chatsworth, CA and Clontech, Mountain View, CA), the 
western blots were blocked in 1% Casein in TBS (Pierce, Rockford, IL) with 0.1% 
Tween- 20, washed with TBST. RGS-His and 6x His antibodies were incubated at 
dilution of 1: 25,000 and 1: 10,000, respectively, for 60 mins. No secondary antibody was 
required. Blots were developed for 5 mins using North2South Cheminluminescent 
substrate for HRP (Pierce, Rockfort, IL), exposed to CL-XPosure film (Pierce, Rockfort, 
IL).  
 
 
Far-Western Blotting Experiments 
 
Far-Western experiments for cell lysates overlayed with purified, non-denatured 
BctA or BmpH was performed using a previously published protocol (174). Briefly, the 
crude extracts containing λcI-TraM were electrophoresed using SDS-PAGE, and 
transferred to a nitrocellulose membrane. The membrane was blocked of free binding 
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sites by incubation with blocking solution 1% Casein TBS for 2 hrs. Then, the membrane 
was incubated with 10 μg purified His-BctA or 30- 50 μg His-BmpH proteins in 15 ml 
1% Casein TBS for 30 mins at room temperature. This incubation allowed BctA or 
BmpH to bind to its potential partners. After washing with TBS T/T (TBS with 0.2% 
Triton X-100, 0.05% Tween 20), the membrane was incubated with antibodies for His tag 
of BctA or BmpH western blot procedure was performed. A negative control Far-western 
blot was incubated with anti-His antibodies but not with purified proteins.  
Anti-TraM Antiserum Generation 
 
To generate TraM antibodies, TraM was subcloned into the pDEST42 expression 
vector, so that TraM was tagged with V5 and 6xhistidine at its C terminal. Full-length 
TraM was subcloned into pENTR vector by using NdeI (forward direction) and SacI 
(reverse direction) restriction enzymes. pENTR-M and pET-DEST42 were recombined, 
according to the manufacture’s instruction to obtain expression clone p42M. p42M was 
checked by enzyme digestion and sequencing. The expression vector p42M was 
transformed into E. coli BL21AI cells.  
TraM-6His was purified from E. coli BL21AI cells by using denatured lysis, 
affinity purification and electro elution methods. Briefly, 25 ml of LB medium was 
inoculated with 500 μl of overnight culture cells of BL21-AI p42M, grown at 370C with 
shaking at 250 rpm. 1 mM final concentration of IPTG were added to the culture at mid-
logarithm phase (OD600nm=0.5). After induction, cell cultures were grown for 2.5 hrs 
further. Cells were harvested by centrifugation at 3500 rpm for 30 min by using a 
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Beckman Coulter Allegra X-15R centrifuge. Cell pellets were then freezed overnight at -
200C. After being thawed, cell pellets were resuspended in 15 ml denatured lysis buffer 
(50 mM NaH2PO4, 300 mM NaCl, 8 M urea, pH 7.5), and 600 μl of proteinase inhibitor 
cocktail (Roche, Indianapolis, IN). The cell suspension was gently rocked at room 
temperature for 2 hrs and then sonicated on ice at 55% for 6 x 30 secs pulse with 30 secs 
rest in between. Lysates were cleared by centrifugation at 2850 g, 40C for 30 mins and 
then applied to TALON cobalt affinity column (Clontech, Mountain View, CA) pre-
equilibrated with 2 x 1ml lysis buffer and 1 x 0.5 ml lysis buffer plus 0.5 ml wash buffer 
(50 mM NaH2PO4, 300 mM NaCl, and 15 mM imidazole, pH 7.5). Column was then 
washed 3 x 1 ml of wash buffer. Immobilized His-tagged proteins were eluted in 3 x 550 
μl fractions (50 mM NaH2PO4, 300 mM NaCl, and 200 mM imidazole, pH 7.5). All 
affinity purified TraM was applied in a prep PAGE gel and electrophoresed. 500 μl of 
proteins was loaded in the large lane, while 50 μl was loaded in a small lane to serve as a 
reference. The reference lane was cut out of the gel and was stained with GelCode Blue 
Stain Reagent (Pierce, Rockfort, IL). Meanwhile, the prep lane was submerged in a small 
amount of TGS buffer and kept at 40C. After staining, the reference gel was used as a 
reference to align the size of TraM in the prep gel. Polyacrylamide gel at TraM expected 
size was cut out of the prep gel, cut into small pieces and subjected for electro elution.  
Protein elution was performed using a Bio-Rad electro eluter 422 (BioRad, 
Hercules, CA), according to manufacturer’s instruction. Briefly, membrane caps were 
soaked in TGS, protein elution buffer, for at least 1 hr at 600C and was placed into the 
bottom of silicone adaptor, filled with TGS, then slided onto the bottom of the elution 
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glass tube with frit. Each tube was filled with TGS and placed gel slices. Protein was 
eluted at 8-10 mA/ glass tube constant current for 6-8 hrs. After the elution was 
completed, proteins were collected from the membrane caps. Proteins were also checked 
by western blot to confirm purification. 
About 5 mg of purified TraM in TGS were submitted to Alpha Diagnostic 
International (San Antonio, TX) for custom antibodies production. Antiseria were 
generated by injected antigen (TraM) to two rabbits five times with 14 days intervals. 
Immune bleeds (antisera) were collected at week 7 and week 9. Final antiserum was 
collected at the end of the procedure (63 days). Antisera were tested by western blot. 
Final bleeds from both rabits were mixed and subjected for affinity purification. 5 mg of 
purified TraM in TGS was dialysed to PBS plus 0.01% SDS, and was applied for 
preparation of affinity column. Antibodies collected from affinity purification were tested 
using ELISA and western blot for purification. 
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Figure 9. pET-DEST42 expression vector map (Invitrogen) 
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Bacterial Two Hybrid Studies 
 
Bacterial two-hybrid screens were performed using the Stratagene 
BacterioMatchII two hybrid system (Agilent Technologies, La Jolla, CA), according to 
the manufacture’s instruction with some modifications. Briefly, bait genes (bctA, bmpH, 
traM or traM mutants) were constructed in fusion with the full-length bacteriophage λ 
repressor protein (λcI) in the bait vector, pBT. Expressions of bait proteins were tested on 
western blots using anti-λcI or anti-TraM antibodies. Target genes (bctA, bmpH, traM 
(orf7), traM mutants, orf5, orf6, etc.) were fused to the N-terminal domain of the α-
subunit of RNA polymerase in the target vector, pTRG. The bait is pulled to the 
λ operator sequence upstream of the reporter through the DNA binding domain of λcI. 
When the bait and target interact, they recruit and stabilize the binding of RNA 
polymerase to at the lacZ promoter, activating the transcription of the HIS3 and aadA 
(Strr) genes. HIS3 encodes a component of the histidine biosynthetic pathway that 
complements a hisB mutation in the reporter strain. The HIS3 gene product is produced 
from the reporter gene cassette at low levels in the absence of transcription activation, 
allowing the reporter strain to grow on minimal medium lacking histidine. The compound 
3-amino-1,2,4-triazole (3-AT) acts as a competitive inhibitor of the HIS3 gene product. In 
the presence of 5mM 3-AT, the reporter strain is unable to grow on media lacking 
histidine. When the reporter strain is co-transformed with hybrid bait and target proteins 
that interact, the RNA polymerase is recruited to the promoter, activates the transcription 
of HIS3 and allows the cells to grow on selection media containing 5mM 3-AT. 
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50 ng of each of the bait and target plasmids were co-transformed, and grown in 
LB rich media for 90 mins. Cells were then washed 3 times by centrifugation at 2000 g 
with 1 ml of M9 His-dropout broth (histidine drop out amino acid supplement in M9 
media additive broth). M9 His-dropout broth: 1X M9 salt (Clontech, Mountain View, 
CA), 0.4% glucose, 0.2 mM andenine HCl, 1X His dropout amino acid supplement 
(Clontech, Mountain View, CA), 1 mM MgSO4, 1 mM Thiamine HCl, 10 μM ZnSO4, 
100 μM CaCl2, 50 μM IPTG. Then, cells were grown in M9 His- dropout broth for 2.5 
hrs before being plated on non-selection plates prepared from M9 His- dropout broth and 
0.17% agar, containing antibiotic selection for both plasmids (25 μg/ml chloramphenicol 
and 12.5 μg/ml tetracycline). Cells were allowed to grow on non-selection plates at 370C, 
overnight. Cells were then replica-plated on selection plates containing 25 μg/ml 
chloramphenicol, 12.5 μg/ml tetracycline 5mM 3-AT, 370C, overnight. The next day, 
cells were replica-plated on double selection plates containing 25 μg/ml chloramphenicol, 
12.5 μg/ml tetracycline, 5 mM 3-AT and 12.5 μg/ml streptomycin. The percentage of 
cells grown on double selection plates was calculated by dividing the number of cells on 
the double selection plate and the number of cells on the non-selection plate. 
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Figure 10: Schematic of the BacterioMatch II two-hybrid system dual reporter 
construct (adapted from Agilent Technologies). 
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Bacterial Sub-cellular Fractionation Experiments 
 
To determine if TraM is associated with the membrane, a cellular fractionation 
was carried out as previously described (77). Briefly, traM was cloned into pDEST42 
vectors so that TraM is tagged with 6xHis at its C terminus. E. coli harboring TraM- x6 
His-V5 construct was harvested and lysed under non-denaturing conditions using 
phosphate-buffered saline (PBS) and sonication. Sonicates were then centrifuged at 1300 
X g to separate crude bacterial debris from total lysate. After addition of protease 
inhibitor cocktail (Roche, Indianapolis, IN), clear lysates were centrifuged at ultra-high 
speed, 265,000 X g for 2.5 hrs to separate total membrane in the pellet and cytoplasmic 
proteins in the supernatant (77). The pellets containing membrane proteins were then 
further centrifuged at high speed in PBS and were sonicated to solubilize membrane 
proteins. Proteins were quantitated and an equal amount of proteins were electrophoresed 
on SDS-PAGE gel, then, transferred to nitrocellulose membranes and subjected to 
Western blotting using anti-His antibodies coupled to horseradish peroxidase RGS-His 
antibodies (Qiagen, Chatsworth, CA). 
To determine if TraM was associated with the inner membrane, cellular 
fractionation experiments to separate the inner and outer membrane fractions of E. coli 
BL21AI p42M cells were performed as previously described (52). Saturated bacterial 
cultures were diluted 1/50 in 25 ml LB medium. When cell density reached an OD595nm of 
0.5 - 0.6, cells were induced with 1 ml of 20 % L-arabinose for 2 h. The culture was 
harvested, centrifuged at 3500 rpm in Beckman X-15R centrifuge for 30 min 40C, 
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washed with phosphate buffer saline (PBS) and resuspended in 1 ml of 50 mM Tris (pH-
7)-20 % sucrose with protease inhibitors. Cells were treated with 40 μl of 0.25 M EDTA-
0.25 mg of lysozyme/ ml (final concentration of 10 mM and 10 μg/ ml, respectively), for 
10 min at room temperature. The periplasmic fraction was isolated from the rest of the 
cells by centrifugation at 8,000 X g for 10 min. The pellet was resuspended in 1 ml of 
sonication buffer (10 mM Tris-HCl pH 7 and proteases inhibitors) and sonicated three 
times for 15 secs each time at (Fisher sonicator, 55% power). Unbroken cells were 
removed by centrifugation at 16,000 g for 2 min, and the clear lysate supernatant 
containing cytoplasmic proteins and inner and outer membranes was removed and 
centrifuged for 1 hr at 31,000 X rpm to pellet the membranes (Beckman Coulter TLA 100 
Ultracentrifuge with a TLA100.3 rotor). The supernatant containing the cytoplasmic 
fraction was removed; the membrane pellet was washed with sonication buffer, 
resuspended in 0.1 ml sonication buffer with 0.5% N-lauroylsarcosine, which selectively 
solubilizes the inner membrane, and centrifuged at 31,000 X rpm for 1 hr. The 
supernatant containing the inner membrane fraction was then removed. The outer 
membrane pellet was washed with sonication buffer with 0.5% N-lauroylsarcosine. The 
final pellet was suspended in 0.2 ml of sonication buffer with 0.5% N-lauroylsarcosine 
and 0.1% sodium dodecyl sulfate (SDS). The proteins in each fraction were quantitated 
by BCA method and measured by Nanodrop 1000 (Thermo Scientific). Proteins were 
added with SDS sample buffer with β-mercaptoethanol, boiled for 10 min, and equal 
amounts of proteins from each fraction was electrophoresed using SDS-PAGE, 
transferred to nitrocellulose membranes and subjected to immuno-blotting using anti-His 
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antibodies coupled to horseradish peroxidase (Clontech, Mountain View, CA). A control 
Western blot was probed with anti-OmpA antiserum that detects a specific outer 
membrane protein, OmpA. Another control Western blot was probed with anti-DnaK 
antiserum that detects a specific cytoplamic protein, DnaK.  
 
 
Construction of traM antisense RNAs 
 
To knock-down TraM expression in B. fragilis LV23, an antisense approach was 
applied. A shuttle vector was constructed so that it carried a traM asRNA fragment 
downstream of cfxA promoter (PcfxA). The pFD288 shuttle vector (167) was used for this 
construction, and the desired vector was called pFD288MAS1, 2 or 3. Figure 25 shows 
the strategy for construction of this shuttle vector. First, cefoxitin pomoter (PcfxA) was 
amplified from the shutter vector pFD351 (136), and then subcloned in pFD288, using 
PstI and BamHI restriction sites. Then, three different traM- antisense fragments were 
amplified from traM in LV23 genomic DNA, subcloned in pFD288P plasmid in opposite 
direction to PcfxA, using PstI and EcoRI restriction sites.  AS1 is complementary to a 
region of 316 nucleotides, covering a putative Shide Dalgano sequence of traM and the 
first 166 nucleotides of traM sequence. AS2 has 179 nucleotides, complementary to a 
similar segment like AS1 but shorter, also complementary to the first 166 nucleotide of 
traM sequence. AS3 is complementary to 120 nucleotides of traM sequence from 
nucleotide 102 to nucleotide 221. AS1, 2 and 3 were subcloned in pFD288P in the 
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opposite orientation to that of PcfxA, so that, when the plasmid was transcribed, AS1, 2 
and 3 RNA would be transcribed in the opposite direction, resulting in mRNA species 
that were antisense to traM mRNA. 
 
 
Table 6: Primers for construction of traM- antisense RNAa. 
 
No Primer name Sequence 
1 EcoRI-10074Fb ATCAGAATTCCCAATGCAAGTTTTCAACGA 
2 EcoRI-10211F ATCAGAATTCTGGGAAATTAACTCCAGAAGACA 
3 BamHI-10389Rc CTCAGGATCCCTGCTGGGGCAGAGTTTATC 
4 EcoRI-M102F ATCAGAATTCTGCCCCAGCAGAAGAAACTA 
5 BamHI-M221R CTCAGGATCCTTGAAAGCTCCTTTGAGTGATTC 
6 PstI-Pcfx-F ATCACTGCAGCCATGTTTATATTATTTATATTTGTT
TGACGAG 
7 BamHI-Pcfx-R CTCAGGATCCAAAATCAGTTCTTTAGCGATTAC 
 
a: AS1 was amplified using primers EcoRI-10074F and BamHI-10389R (the numbers 
appear in these primer names indicate the start nucleotide of the primers in BTF-37 
contig). AS2 was amplified using primers EcoRI-10211F and BamHI-10389R. AS3 was 
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amplified using primers EcoRI-M102F and BamHI-M221R (the numbers appear in these 
primer names indicate the start nucleotide of the primers in TraM). Red nucleotides show 
restriction enzyme sequences. b: F: forward primer. c: R: Reverse primer. 
  
 
pFD288MAS1, 2, and 3 were transformed into the conjugation-competent E. coli 
cells HB101-RK231 (the RK231 plasmid provides necessary products for DNA transfer 
by conjugation). One control was the transformation of the construct pFD288P that 
carries just the promoter PcfxA. Another control was the transformation of pFD351 
shuttle vector that carries the whole cfxA gene instead of TraM asRNA fragment. The 
presence of the vectors in the cells was also confirmed by PCR. 
A mating experiment of HB101-RK231-pFD288MAS and B. fragilis strain LV23 
to select for transconjugants TcR (select for LV23) and CcR (select for pFD288MAS) was 
carried out. 
The requirement of TraM for conjugation was tested by performing quantitative 
conjugation assays from the donor Bacteroides LV23-TraM AS to the recipients E. coli 
HB101 or B. fragilis TM4000. Transconjugants were selected by ampicillin and 
streptomycin resistance. Conjugation frequency was calculated relative to the number of 
donors.  
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Conjugation Experiments 
 
E. coli to B. fragilis mating 
Mating experiments to transfer traM-antisense carrying plasmids from E. coli 
HB101 RK231 to B. fragilis LV23 were performed as previously described (67).  The E. 
coli donor strains were grown overnight aerated in LB media containing selective 
antibiotics 25 μg/ ml kanamycin for RK231 and 50 μg/ ml spectinomycin for pFD288P 
or pFD288MAS plasmids. The B. fragilis LV23 recipient strain was grown overnight in 
BHIS broth (brain heart infusion broth supplemented with hemin) with 5 μg/ ml 
tetracycline for LV23 strain selection.  500 μl of the recipient overnight culture was 
diluted into 25 ml pre-reduced BHIS (1:50 ratio) and grown to mid-logarithmic phase 
(OD660nm = 0.6) in anaerobic chamber. About 1 hr and 30 mins after the subcultures of B. 
fragilis recipients, the E. coli donor was subcultured from the overnight culture to LB 
media in 1:50 ratio, and was grown to early-logarithm phase (OD600nm = 0.4). The donor 
and recipient cultures were mixed in 1:1, 1:5 and 1:10 ratios, in which, the donor was 
used at 100 μl. The mixtures were centrifuged in 1.5 ml tubes for 2 mins at 3600 rpm in 
Eppendorf 5415R centrifuge. Supernatants were discarded. Pellets were resuspended in 
50 μl BHIS and plated onto the centers of plain BHIS plates, which were allowed to dry 
out and incubated aerobically overnight at 370C. 100 μl of each culture (donor and 
recipient) was plated onto BHIS plates supplemented with clindamycin and gentamycin 
and was incubated anaerobically at 370C as negative controls. After overnight incubation, 
the mixture cells of donor and recipient were scraped from BHIS plates and plated on 
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pre-reduced BHIS plates supplemented with tetracycline for selection for LV23 strain, 
clindamycin for selection of the shuttle vectors and gentamycin for clearance of E. coli 
cells, and were grown anaerobically at 370C for 24 to 48 hrs. Transconjugants were 
collected and transconjugant plasmid DNA was prepared and checked by restriction 
enzyme analysis.  
 
B. fragilis to E. coli quantitative mating 
Quantitative B. fragilis to E. coli filter mating was performed as previously 
described (183). B. fragilis strains containing pFD288MAS shuttle vectors or other 
control plasmids were used as donors. E. coli HB101 cells were the recipients. 
Stationary-phase cultures of the donors were used to inoculate fresh BHIS medium at a 
1:50 dilution under anaerobic conditions. Subcultures were induced with 1 μg of 
tetracycline/ml after 1.25 hr, and, were grown further for 3 to 4 hrs (optical density at 660 
nm reached 0.6). The recipient E. coli cells were subcultured at a 1:100 dilution, 2 hrs 
after subcultures of the B. fragilis donors. Recipients were grown aerobically until optical 
density at 600 nm was about 0.55. Then, 2.5 ml of donor were applied to 0.45-μm-pore-
size Nalgene filters, which were vacuumed to remove medium, then washed with 10 ml 
of sterile modified phosphate buffered saline (MPBS) (80 mM Na2HPO4, 2 mM 
NaH2PO4, 1.45 mM NaCl, pH 6.9), then, mixed with 2.5 ml of the recipient cells, 
vacuumed to remove medium. Nalgene filters containing mixture of cells were 
aseptically transferred to BHIS agar plates using a scalpel fitted with a disposable blade, 
and incubated anaerobically overnight. Following incubation, filters were placed in 5 ml 
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of MPBS and vortexed vigorously for 15 secs to loosen cells and suitable dilutions were 
plated on selective BHIS media (streptomycin and spectinomycin for selection of HB101 
and plasmid pFD288, respectively) and were allowed to grow aerobically. Conjugation 
frequency was calculated by dividing the number of transconjugants obtained by the total 
number of viable donor cells. Viable donor cells were measured by plating serial 
dilutions of the donor strains onto selective medium. 
 
B. fragilis to B. fragilis quantitative mating 
Quantitative B. fragilis to B. fragilis filter mating was performed as previously 
described (183). B. fragilis strains containing pFD288MAS shuttle vectors or other 
control plasmids were used as donors. B. fragilis TM4000 was the recipients. Stationary-
phase cultures of the donors and recipient were used to inoculate fresh BHIS medium at a 
1:50 dilution under anaerobic conditions. Subcultures of the donors were induced with 1 
μg of tetracycline/ml after 1.25 hr, and were grown further for 3 to 4 hrs (optical density 
at 660 nm reached 0.6). Then, mating experiments on Nalgene filters were carried as 
described in mating experiments from B. fragilis to E. coli. Nalgene filters containing 
mixture of cells were aseptically transferred to BHIS agar plates and incubated 
anaerobically overnight. Following incubation, filters were placed in 5 ml of MPBS and 
vortexed vigorously for 15 secs to loosen cells and suitable dilutions were plated on 
selective BHIS media (clindamycin for selection of the shuttle vectors and rifampicin for 
selection of the recipients). Conjugation frequency was calculated by dividing the number 
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of transconjugants obtained by the total number of viable donor cells. Viable donor cells 
were measured by plating serial dilutions of the donor strains onto selective medium. 
 
 
Site Directed Mutagenesis 
 
Site directed mutations in traM were generated using Stratagene’s QuikChange 
Site-Directed Mutagenesis Kit, according to the manufacturer’s instruction. The 
oligonucleotide primers containing the designed mutation were designed complementary 
to opposite strands of the vector encoded TraM. Extension of the primers created a 
mutated plasmid containing staggered nicks. After PCR, the product was treated with 
DpnI enzyme. The DpnI endonuclease is specific for methylated and hemimethylated 
DNA and is used to digest parental DNA plasmid and select for mutation-containing 
newly synthesized DNA. The nicked vector DNA containing the desired mutations was 
then transformed into XL-1 Blue supercompetent cells. The cells repair the nick in the 
mutated plasmid. The mutated plasmids were sequenced to confirm mutations. 
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Table 7: Primers for generation of site directed mutagenesis in traM 
 
 Primer Sequence 
1 F66A-Fwd 5'-
GAGAGATAAAAAGTAAAGCTGAATCACTCAAAGGAG
CTTTCA-3' 
2 F66A-Rev 5'-
TGAAAGCTCCTTTGAGTGATTCAGCTTTACTTTTTATC
TCTC-3' 
3 F66R-Fwd 5'-
GAGAGATAAAAAGTAAACGTGAATCACTCAAAGGAG
CTTTCA-3' 
4 F66R-Rev 5'-
TGAAAGCTCCTTTGAGTGATTCACGTTTACTTTTTATC
TCTC-3' 
5 L69G-Fwd 5'-
GAGATAAAAAGTAAATTTGAATCAGGTAAAGGAGCT
TTCAATAAATCTTCTG-3' 
6 L69G-Rev 5'-
CAGAAGATTTATTGAAAGCTCCTTTACCTGATTCAAA
TTTACTTTTTATCTC-3' 
7 L69R-Fwd 5'-
GAGATAAAAAGTAAATTTGAATCACGCAAAGGAGCT
TTCAATAAATCTTCTG-3' 
8 L69R-Rev 5'-
CAGAAGATTTATTGAAAGCTCCTTTGCGTGATTCAAA
TTTACTTTTTATCTC-3' 
9 L123G-Fwd 5'-
CTAGAATCCGAGAAAAGGAAGGTGAACAACAAATAA
AAGGATTTCCTAC-3' 
10 L123G-Rev 5'-
GTAGGAAATCCTTTTATTTGTTGTTCACCTTCCTTTTC
TCGGATTCTAG-3' 
11 L123R-Fwd 5'-
CTAGAATCCGAGAAAAGGAAAGGGAACAACAAATA
AAAGGATTTCCTAC-3' 
12 L123R-Rev 5'-
GTAGGAAATCCTTTTATTTGTTGTTCCCTTTCCTTTTC
TCGGATTCTAG-3' 
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13 L123S-Fwd 5'-
AATCAAGCTTCTAGAATCCGAGAAAAGGAATCGGAA
CAACAAATAAAA-3' 
14 L123S-Rev 5'-
TTTTATTTGTTGTTCCGATTCCTTTTCTCGGATTCTAG
AAGCTTGATT-3' 
15 M154A-Fwd 5'-
CAAGATGCAAGAAGAAGCTGAGCTTTTTAAAATGCA
AATGG-3' 
16 M154A-Rev 5'-
CCATTTGCATTTTAAAAAGCTCAGCTTCTTCTTGCATC
TTG-3' 
17 M154G-Fwd 5'-
CAAGATGCAAGAAGAAGGTGAGCTTTTTAAAATGCA
AATG-3' 
18 M154G-Rev 5'-
CATTTGCATTTTAAAAAGCTCACCTTCTTCTTGCATCT
TG-3' 
19 M154R-Fwd 5'-
CAAGATGCAAGAAGAAAGGGAGCTTTTTAAAATGCA
AATG-3' 
20 M154R-Rev 5'-
CATTTGCATTTTAAAAAGCTCCCTTTCTTCTTGCATCT
TG-3' 
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CHAPTER IV  
EXPERIMENTAL RESULTS 
 
 
BctA is Essential for Conjugation from B. fragilis LV23 
 
Previously, our laboratory reported the capture of BTF-37, a 37kb conjugative 
transposon, from a clinical B. fragilis isolate, LV23 (181). BTF-37 alone is capable of 
facilitating transfer of DNA not only in B. fragilis but also in E. coli (181). Due to many 
repeat A-T rich regions which hinders the sequencing process, only 16kb of BTF-37 was 
sequenced. This 16kb region carries 11 ORFs. By sequence homology analysis with other 
Bacteroides known transfer factors, and by RT-PCT studies, these 11 genes likely 
correspond to the transfer region of BTF-37 (77). Of these 11 ORFs, bctA is an ORF 
highly conserved between different Bacteroides transposons. 
BctA encodes a putative coupling protein of BTF-37 CTn (77). It is identical to 
the putative coupling protein BctA of B. fragilis conjugative plasmid pBF4, 98% 
identical to that of the B. fragilis NCTC9343, 74% to the B. fragilis YCH46 strain from 
Japan, and 48% to a BctA homolog from the B. fragilis CTnDOT conjugative transposon 
(77). Computer analysis also reveals that BctA has two Walker-box-sequences, ATP-
hydrolysis motifs, as characteristic of a coupling protein. Previous studies from our 
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laboratory also shown that BctA has a signal sequence required for membrane 
localization and that it is indeed associated with the membrane. Moreover, BctA 
expression is upregulated under conjugation conditions and purified BctA migrates as a 
tetramer under non-denaturing PAGE (77). 
To determine if BctA is required for conjugation in B. fragilis LV23, we 
generated a bctA null mutant. The traditional method is to introduce into a B. fragilis 
parent strain a suicide vector (pFD516) carrying a disrupted form of bctA gene (the 
middle region of bctA gene is disrupted by a cfxA gene). Previous work from our 
laboratory has shown it was very difficult to generate such a null mutant in the parental 
LV23 strain. Therefore, a bctA null mutant was generated from the parental 
TM4000BTF-37 strain. TM4000 is a transfer deficient strain. TM4000BTF-37 is a DNA 
transferrable strain carrying BTF-37 CTn generated by introduction of pBTF-37 into 
TM4000. The scheme for the selection of the TM4000BTF37bctA transconjugants was 
depicted in figure 11A. Figure 11B shows evidence of the presence of the disrupted bctA 
gene in the chromosomes of transconjugants, as seen by the PCR products of the 
amplifications of the right arm of the disrupted bctA gene, a region of about 1.6kb 
covering a cfxA gene insertion and the right flanking region of bctA. This evidence 
confirmed that the TM4000BTF37bctA transconjugants are true null mutants. First, this 
amplification cannot be from the original suicide vector because this suicide vector 
cannot replicate in B. fragilis, thus it should not present in the transconjugatns after 
several passages. Second, if the construct can insert into somewhere into the 
chromosome, we expect to be able to amplify not just the disrupted form of bctA but also 
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its orginal gene. Third, if bctA was not truly deleted due to the non-resolution of the 
suicide vector, a large portion of the suicide plasmid is still present in the chromosome, 
then a short species of 1.6kb PCR product should have not been detected. 
To test for the transfer frequency of TM4000BTF37bctA null mutant, a shuttle 
plasmid pGAT400 was introduced into each test strain by conjugation from E. coli 
HB101 donor, and then this pGAT400 plasmid was used as a transferrable DNA to be 
measured in quantitative conjugation experiments. Quantitative conjugation experiments 
were carried out from donors TM4000BTF37bctA-GAT400 to the transfer deficient strain 
TM4000. Positive controls were mating experiments from donors LV23GAT400 and 
TM4000BTF37-GAT400 to TM4000. A negative control was the mating from TM4000-
GAT400 to TM4000. Figure 11C shows that BctA is indeed required for the conjugation 
of BTF-37 CTn in B. fragilis. bctA KO strains were totally defective in DNA transfer 
activity. 
A complementation assay was carried out to test if the re-introduction of BctA 
into BctA KO strain could recover DNA transfer activity. A shuttle plasmid (pFD288-
BctA) carrying bctA was introduced into TM4000BTF37BctAGAT400. However, the 
complementation assay did not work, most likely because BctA was not successfully 
expressed in pFD288 shuttle vector. This may due to two reasons. First, the construction 
of bctA into pFD288 did not include any promoter region for successful expression of 
BctA. A reconstruction of pFD288-BctA including an upstream region of bctA, which 
most likely carries an original bctA promoter region, may solve this issue. Another 
solution is to use a promoter known to work well in B. fragilis to drive the expression of 
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bctA, such as cefoxitin promoter PcfxA. Second, the fact that pFD288 is a low copy 
shuttle vector obviously affects the level of expression of BctA. The use of a better 
shuttle vector system may help solving this problem. The lack of an anti-BctA antibody 
also hindered the verification of BctA expression. 
However, the lack of a supporting complementation assay data does not preclude 
the likelihood that BctA is truly essential for conjugation mediated by BTF-37 in B. 
fragilis. 
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A. 
 
B. 
 
C. 
 
Figure 11. BctA is required for conjugation mediated by CTn BTF-37 in B. fragilis. 
A) Strategy to generate a bctA mull mutant in B. fragilis TM4000BTF-37. B) Evidence 
for the presence of bctA disrupted construct in transconjugant chromosomes. C) bctA null 
mutants (TM4000BTF37bctA #5 and #8) abolishes DNA transfer capacity of BTF-37 as 
measured by transfer frequency of GAT400 plasmid. 
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BTF37 Genes are Involved In Conjugation Process in B. fragilis LV23 
 
Although the formation of the conjugal apparatus is well studied in other 
conjugative systems such as A. tumefaciens Ti plasmid and E. coli F and RP4 plasmids, 
little is known about its structure and function in Bacteroides spp. (181). BTF-37, a 
conjugative transposon isolated from the B. fragilis clinical isolate LV23, harbors genes 
encoding conjugal apparatus proteins and confers mobility on non-mobile plasmids 
(181). To identify important conjugal apparatus components, we investigated the 
expression of BTF-37 genes under conjugation conditions, i.e. when Bacteroides cells are 
stimulated with a low level of tetracycline (≤ 1 µg/mL). Under these conditions, the 
frequency of conjugal transfer has been shown to be elevated 1,000-10,000 fold (160, 
173), and is likely directly related to the increased expression of proteins that assemble 
into the conjugal apparatus. Thus, we hypothesized that if transcript production from a 
BTF-37 gene was up-regulated under tetracycline induction conditions, that gene product 
may be involved in the DNA transfer process.  
Using semi-quantitative RT-PCR, we found that expressions of all 11 ORFs in the 
known 16 kb sequence of BTF-37 were up-regulated when B. fragilis cells were exposed 
to tetracycline. After normalization with 16S rDNA expression, the transcripts of the 11 
ORFs were up-regulated 1.2 to 2.1-fold.  traM- orf7 transcription was elevated 1.5 fold, 
similar to that previously observed for bctA (77). 
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We have previously reported that bctA expression is elevated to a maximum of 
2.5-3 fold using real time RT-PCR and spot densitometry, respectively (77). These low 
(but consistently reproducible) levels of transcript up-regulation are likely due to the gene 
products being membrane-associated or integral membrane proteins; thus they cannot be 
highly over-expressed without deleterious effects to the cells. Further, actual DNA 
transfer events from donors to recipient bacteria occur very quickly (likely in secs), and 
only one conjugal apparatus is finally formed to connect the donor with the recipient 
[40](181). Therefore, these small increases in gene expression are likely sufficient for the 
production of a functional conjugal apparatus. Other laboratories have also reported 
similarly low increases in conjugal apparatus gene expression that correlate with 
increased DNA transfer (C. Jeffrey Smith, personal communication). We therefore 
conclude from these results that this up-regulation of conjugal apparatus gene expression 
from 1.2-2.1 fold indicated that all 11ORFs of BTF-37 are involved in the conjugation 
process. 
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Figure 12. BTF37 conjugative transposon 
 
 
 
A. 
 
 
 
B. 
 
Gene 16S TetQ ORF1 ORF2 BctA ORF4 ORF5 ORF6 ORF7 ORF8 ORF9 ORF10 ORF11
Ratio 1 4.1 1.7 2.1 1.5 1.5 1.3 1.2 1.5 1.4 1.4 1.2 1.3 
 
Figure 13: mRNA expression of 11 genes in the 16 kb sequenced region of BTF37 in 
conditions with and without tetracycline induction. A) a representative 1% agarose gel 
profile. +: Tc induction; -: no Tc induction; B) Ratio of gene expression in Tc induction 
condition vs no Tc, normalized to the expression of 16S transcripts. 
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Identification of BctA and TraM Interaction Partners 
 
The function of a coupling protein is to couple the relaxosome complex to be 
transferred though the conjugal apparatus to the recipient. The coupling protein localizes 
at the base of the conjugal apparatus and interacts with both the relaxosome complex and 
the conjugal apparatus (29, 59, 61). In B. fragilis, such interaction partners of the putative 
coupling protein BctA have not been identified. In E. coli and A. tumefaciens, 
interactions of many mobilization proteins and conjugal apparatus components with the 
coupling protein were initially identified by two-hybrid system and then confirmed by 
biochemical experiments (5, 57, 69, 105, 174). Thus, to identify BTF-37 conjugal 
apparatus proteins interacting with the coupling protein, similar approaches were 
employed. 
First, Bacteriomatch II two-hybrid system (Stratagene-Agilent Technologies, 
(43)) was employed to screen for gene products that interact with the putative coupling 
protein BctA. Briefly, individual BTF37 ORFs were cloned into the “prey” vector, 
pTRG; bctA was cloned into the “bait” vector, pBT. The reporter cells (XL-1 Blue MFR 
KanR) were co-transformed with 50 ng each of bait and prey plasmids, phenotypically 
expressed transformant genes in His- minimal media, plated on nonselective plates for 
24hrs then replica plated on selective media containing 5mM 3AT, and then on dual 
selective plates containing 5mM 3AT and streptomycin. All plates had 25mM 
chloramphenicol and 12.5μM tetracycline throughout to select for bait and prey plasmids. 
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The strength of interaction was calculated as the percentage of the co-transformed 
colonies that grown on the double selection plates. This was calculated by dividing the 
number of colonies on double selection plate for the number of colonies that grown on 
the non-selection plate. BctA was also exmanined for its stable protein production 
(Figure 14A). Our results of the bacterial two hybrid experiment in Figure 14B indicate 
that BctA interacts with ORF7 and ORF8 and that the interaction with ORF7 is stronger 
than with ORF8. From sequence homology analysis, ORF7 and ORF8 are homologous to 
TraM and TraN in other Bacteroides spp. CTn’s, respectively. 
Of particular interest, BTF-37 ORF7 (TraM) is a 393 amino acid protein, and has 
92% sequence identity to TraM in B. fragilis NCTC9343, 61% to TraM of B. fragilis 
YCH46, 32% to TraM of B. thetaiotaomicron CTnDOT and 28% to B. vulgatus CTn341. 
It is predicted to be a membrane protein by the TMHMMM 
(http://www.cbs.dtu.dk/services/TMHMM/) and DAS 
(http://www.sbc.su.se/~miklos/DAS/maindas.html) membrane predicted programs (37). 
Moreover, deletion studies from CTn341 shown that TraM is required for conjugation 
(7), indicating that TraM is an important component of the conjugal apparatus in 
Bacteroides spp. Thus, we decided to focus our study on ORF7 (TraM). 
Another two-hybrid screen was performed, in which, traM was used as the bait 
and other genes were constructed in the target vector. Our results further confirmed that 
TraM interacts with BctA (both BctA full-length and N-terminal truncation). 
Interestingly, TraM interacts with BmpH and ORF8 (TraN). A positive control for BmpH 
interaction was the interaction between E. coli TraG and BmpH. Work from our 
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laboratory has previously  shown that TraG of E. coli RP4 plasmid system interacts with 
the B. fragilis relaxase BmpH of the Tn5520 mobilizable plasmid. 
This was the first time a two-hybrid approach was used to study the interactions 
of Bacteroides spp. conjugal apparatus component proteins with a putative coupling 
protein as well as a relaxase. These data indicate that TraM interacts with BctA, ORF8 
(TraN) and BmpH, of which, the interaction of TraM with BctA is strongest. Thus, TraM 
is likely a conjugal apparatus component protein at the base of the CA and interacts with 
the putative coupling protein BctA. This in vivo interaction between TraM and BctA is 
the first demonstration of an interaction of the CP with a CA component protein in 
Bacteroides spp. This is also the first demonstration of a CA component protein in 
Bacteroides spp. interacting with a relaxase. In E. coli F plasmid conjugative system, the 
relaxase forms a complex with some other partners such as IHF, TraM and TraY but they 
are mostly cytoplasmic proteins and not involved in the CA (142). Thus, if this 
interaction is true, it is an interesting finding, supporting the idea that the conjugation 
molecular mechanism in Bacteroides spp. is distinct from that of E. coli. 
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A. 
B. 
 
 
Figure 14: Bacterial two-hybrid analysis of interactions between BctA and other 
BTF37 gene products (data from a representative experiment). A. Western blot shows 
full-length BctA in fusion with λ-cI in the bait vector. Cells: reporter cells (XL-1 Blue 
MFR KanR), pBT: reporter cells expressing the bait vector alone, pBT-BctA: reporter 
cells expressing BctA in bait vector. B. Interactions of BctA with other BTF-37 gene 
products. Individual BTF37 ORFs were cloned into the “prey” vector; bctA was cloned 
into the “bait” vector. The reporter cells (XL-1 Blue MFR KanR) were co-transformed 
with 50 ng each of bait and prey plasmids, phenotypically expressed transformant genes 
in His- minimal media, plated on nonselective plates for 24hrs then replica plated on 
selective media containing 5mM 3AT, and then on dual selective plates containing 5mM 
3AT and streptomycin. All plates had 25mM chloramphenicol and 12.5μM tetracycline 
throughout to select for bait and prey plasmids. 
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Figure 15: Bacterial two-hybrid analysis of interaction of ORF7 (TraM) with other 
BTF-37 gene products (data from a representative experiment). A. Western blot shows 
full-length ORF7 (TraM) in fusion with λ-cI (a total MW of about 72kD) expressed in 
the bait vector. Cells: reporter cells (XL-1 Blue MFR KanR), pBT: reporter cells 
expressing the bait vector alone, pBT-ORF7: reporter cells expressing ORF7 (TraM) in 
the bait vector. B. Interactions of ORF7 (TraM) with other BTF-37 gene products. BctA 
truncation is a construct that does not have the N terminal cleavage signal of BctA. 
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Hypothesis  
 
Of all the putative conjugal apparatus genes encoded by BTF-37, we were 
interested in ORF7 (TraM) because our bacterial two-hybrid data showed  that TraM 
strongly interacted with the putative coupling protein BctA and that it also interacted with 
the relaxase BmpH. Computer analysis of our BTF-37 TraM showed that it harbors 
characteristics of a required conjugal apparatus protein. First, this 393 amino acid protein 
exhibits sequence conservation with other Bacteroides spp. conjugal apparatus proteins, 
i.e., 92% sequence identity to TraM in B. fragilis NCTC9343, 61% to TraM of B. fragilis 
YCH46, 32% to TraM of B. thetaiotaomicron CTnDOT and of B. vulgatus CTn341. 
Second, TraM was predicted to be associated with the membrane, suggesting its function 
as a member of the transverse-membrane mating channel. Third, previous study shown 
that our TraM homolog in B. vulgatus CTn341 is required for conjugation, indicating that 
our BTF-37 TraM may also be important for conjugation in B. fragilis (7). Moreover, our 
preliminary data indicated that TraM interacts with both the putative coupling protein 
BctA and the relaxase BmpH, suggesting a special role of TraM in DNA transfer process 
in B. fragilis.  
We, therefore, hypothesized that TraM is an important conjugal apparatus protein 
of the conjugative transposon BTF-37. If TraM is an important member of the 
Bacteroides spp. conjugal apparatus, then its function must be elucidated in more detail. 
In the studies described below, we thus demonstrated that 1) TraM expression is indeed 
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upregulated under conjugation conditions; 2) TraM associated with the inner-membrane 
and 3) TraM is required for DNA transfer process in B. fragilis. Moreover, we also 
investigated the interaction of TraM with its important putative partners, the putative 
coupling protein BctA and the relaxase BmpH. 
 
 
Figure 16. Homology of some of Bacteroides conjugative transposons. 
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Figure 17. Summary of conjugal apparatus mutation studies in CTn341, showing 
the requirement of TraM for conjugation. Adapted from Bacic, J. Bacteriol, 2005 (7). 
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traM Expression is Upregulated under Conjugation Conditions 
 
TraM is a member of the putative conjugal apparatus operon of the conjugative 
transposon BTF-37. If TraM is truly a conjugal apparatus protein, its expression most 
likely is up-regulated under conjugation condition. In fact, our reverse transcriptase PCR 
study showed that traM expression, along with other genes of the BTF-37 contig was 
upregulated when B. fragilis conjugation condition was induced by tetracycline. Thus, we 
began our in-depth study of TraM by more accurately quantitating its gene expression 
levels under conjugation conditions. We used SYBR-Green based fluorescence for 
detection and quantification of traM expression by fully-quantitative real-time PCR (Q-
PCR). The expression of both the 16S rDNA and tetQ genes was used as controls. Q-
PCR data was analyzed using the ΔΔCt method (77). tetQ was used as a positive control, 
since it has been previously observed that tetQ transcription is up-regulated ~10 fold 
upon tetracycline exposure (77). 
Q-PCR revealed that traM gene expression was up-regulated ~2-fold under 
conjugation (induction) conditions; thus further strengthening our hypothesis that TraM is 
required for Bacteroides spp. conjugation.   
  
98
A. B. 
 
C. 
 
Figure 18. Q-PCR standard curves of 16s rDNA (A), traM (B) and tetQ (C). 
 
 
 
Figure 19. traM gene expression under 
conjugation conditions. Adjusted relative 
expression values were calculated from 
mean ΔCt values of three replicate Q-PCR 
reactions. 
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TraM Interacts with Both The Coupling Protein BctA and The Relaxase BmpH 
 
As presented above, we identified by bacterial two-hybrid analysis that TraM 
strongly interacts with both the coupling protein BctA and the relaxase BmpH. In fact, by 
performing more quantitative study, we further confirmed that BctA and BmpH interacts 
with TraM in E. coli bacterial two hybrid system. Bacterial two-hybrid experiments were 
carried out as described in the experimental methods. The strength of interactions were 
calculated as the percentage of the positive colonies showing the interaction of the bait 
and the target proteins on the double selection plates with the original number of colonies 
grew on the non-selective plates. All experiments were repeated in triplicate. As can be 
seen from figure 20, TraM interaction with BctA is stronger than that with BmpH. 
Moreover, when TraM was expressed in the bait vector, BctA in the target vector, the 
strength of interaction of TraM with BctA is not as strong as that of BctA and TraM 
(when BctA was in the bait and TraM in the target vector). This was probably due to the 
different level of expression of proteins in the bait and the target. We could evaluate the 
level of protein expression in the bait vector by performing a western blot using anti-λcI 
antibodies, antibodies against the fusion domain of the bait. However, we cannot evaluate 
the level of production of the target due to the lack of necessary antibodies. However, 
TraM and BctA either in the bait-target or target-bait relationships still show strong 
interactions with each other. 
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This was the first time a two-hybrid approach was used to study the interaction 
between Bacteroides spp. conjugal apparatus component proteins with a putative 
coupling protein and a relaxase. These interactions indicate that TraM is likely a conjugal 
apparatus component protein at the base of the conjugal apparatus and interacts with the 
putative coupling protein BctA. This in vivo interaction between TraM and BctA is the 
first demonstration of an interaction of a coupling protein with a CA component protein 
in Bacteroides spp. This is also the first demonstration of a CA component protein in 
Bacteroides spp. interacting with a relaxase. It is an interesting finding, supporting the 
idea that the conjugation molecular mechanism in Bacteroides spp. is distinguished from 
that of E. coli. 
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B. 
 
 
Figure 20: Bacterial two-hybrid analysis of A) Interaction of TraM with BctA, B) 
Interaction of TraM with BmpH. 
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A more direct approach to support our bacterial two-hybrid protein interaction 
studies is one based on co-immunoprecipitation analyses. However, due to problems with 
compatibility and selection of available expression vectors, Far-Western experiments 
instead of co-immunoprecipitation analysis were performed to investigate the interaction 
of TraM with BctA and BmpH in vitro. Briefly, 6His-BctA and 6His-BmpH were 
expressed in Xl-1 Blue and BL-21 AI cells, respectively. Then the proteins were purified 
using native purification lysis buffer and TALON cobalt affinity column (histidine 
affinity column). Native proteins were eluted with elution buffer containing 200 mM 
imidazole. The crude extract expressing λcI-TraM from pBT-M vector and control cells 
(Xl-1Blue cells and XL1-Blue cells carrying p-BT vector alone) were electrophoresed on 
SDS-PAGE gel, then were transferred to a nitrocellulose membrane. After blocking, the 
membrane was incubated with purified His-BctA or His-BmpH proteins, then with anti-
RGS His antibodies, antibodies specifc for histidine tag of BctA or BmpH. After that, 
western blot was performed as normal. A negative control Far-western blot was 
incubated with anti-His antibodies but not with purified proteins to show non-specific 
binding of antibodies. Figure 21 showed the presence of His-BctA at the right MW of λ-
cI TraM (~70kD) when purified His-BctA overlayed on membrane harbouring TraM. 
This further confirmed that BctA interacted with TraM.  
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Figure 21: Interaction of λcI-TraM with BctA. 25 μl of control cell lysates (1: XL-1 
Blue cells, 2: XL-1 Blue cells carrying control vector pBT) and of Xl-1 Blue cells 
expressing λcI-TraM were electrophoresed and processed for: blot A: western detection 
of TraM, blot B: Far western analysis overlaid with native 6His-BctA, blot C: antibody 
Far western control blot. Arrow indicates full-length λcI-TraM at 70 kD. 
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Moreover, a far western experiment was also carried out to confirm that BmpH 
interacted with TraM. Because we encountered difficulty in detecting interaction of 
BmpH and TraM in a far western experiment, we tried to obtain a better extraction of 
TraM by utilizing different lysis methods. In figure 22, lane 3 and 4 are cell lysates 
expressing TraM but with two different lysis methods, 3) using Sarkorsyl detergent and 
4) using 1.5% Tween. Overlaid BmpH showed a stronger band interacting with TraM in 
lane 4 than lane 3, most likely due to the different lysis conditions. Although this result 
was observed only one time, our result still shows that BmpH interacts with TraM in 
biochemical assay, supporting the result in the bacterial two hybrid assay. This was 
further comfirmed by our far western experiments for interaction of BmpH with TraM 
mutant L123S, which will be discussed later. This hard-to-produced data may be because 
of the following reasons: 1) purified BmpH is hard to maintain a good native structure for 
far-western experiments and 2) the interaction of TraM with BmpH is weaker than that 
with BctA, and therefore, is harder to be detected on a far western experiment. BmpH has 
high pI of 9.5, has large stretches of positively charge amino acids and is multifunctional. 
Thus, as a result, BmpH may non-specifically aggregate in self and non-self associations, 
hindering the interaction with TraM on the membrane in a far western experiment. 
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Figure 22: Interaction of λcI-TraM with the relaxase BmpH. 25μl of control cell 
lysates (1: XL-1 Blue cells, 2: XL-1 Blue cells carrying control vector pBT) and of Xl-1 
Blue cells expressing λcI-TraM with two different lysis methods with Sarkosyl detergent 
(3) and 0.5 % Tween 20 (4) were electrophoresed and processed for: A: Far western 
analysis overlaid with 30 μg native 6-His-BmpH/ 15 ml far western incubation solution, 
blot B: antibody Far western control blot.  
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TraM is Associated with The Inner Membrane 
 
The conjugal apparatus must be a membrane-traversing channel so that DNA can 
pass through from the donor to the recipient bacteria. In fact, studies in E. coli and A. 
tumefaciens indicate that most of conjugal apparatus proteins are membrane associated 
(63, 100). Computational analysis from TMHMM and DAS transmembrane predicted 
servers indicates that TraM is a membrane protein and aa14-30 from the N terminal of 
TraM are in the membrane spanning region. Moreover, if our BTF-37 TraM truly directly 
interacts with the two key proteins of the conjugation, the coupling protein BctA and the 
relaxase BmpH, it is most likely that TraM is associated with the membrane. In addition, 
mutational analysis of CTn341 (another Bacteroides sp CTn) show that TraM is required 
for Bacteroides conjugal transfer (7). Thus, TraM is most likely a membrane associated 
protein required for B. fragilis conjugation; and the interaction between TraM and BmpH 
may be required for TraM function in the CA. Moreover, because the potential coupling 
protein BctA is expected to be associated with the inner membrane, TraM is also 
expected to be in the inner membrane because it interacts with both BctA and the 
relaxase BmpH. 
First, a simple cell fractionation was applied to determine if TraM is located in the 
membrane or cytoplasmic fraction. In this experiment, cells expressing TraM was 
separeated into cytoplasmic fraction and membrane fraction by using high speed 
centrifugation. We have observed that TraM was strongly associated with the membrane 
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fraction and it was not detected in the cytoplasmic fraction. Interestingly, a band above 
TraM was observed at about 55kD. This is likely full-length TraM that was completely 
processed for signal-sequence cleavage. Although TraM has no computationally 
predicted signal sequences, there is still a high possibility that TraM has a signal 
sequence as it is a membrane protein. We have observed this for other Bacteroides spp. 
CA proteins as well (BctA (77)).  
To further examine if TraM is associated with the inner membrane, another 
cellular fractionation assay was performed to separate inner and outer membrane 
fractions, using high speed centrifugation, sonication and 0.5% N-lauroylsarcosine (as 
described in the experimental methods). 
Figure 23 shows membrane fractionation of TraM-(6) His. As seen in the blot 
probed with OmpA antibodies, the membrane fractionation is still not totally clean, as 
indicated by the presence of some outer membrane protein OmpA in both inner 
membrane fraction (IM) and outer membrane fraction (OM). However, the majority of 
TraM was shown in the IM fraction. This infers that TraM most likely associates with the 
inner membrane. This localization of TraM is speculated to support the interaction of 
TraM with BctA at the base of the CA and also with the relaxosome via the relaxase 
BmpH from the cytosol. 
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Figure 23. TraM is associated with membrane fractionation. P: Periplasmic fraction, 
C: Cytoplasmic; IM: Inner membrane; OM: Outer membrane. 12μg of total proteins/lane. 
A) SDS-PAGE gel stained with Coomassive blue. B) blot probed with 6HIS antiserum 
for detection of TraM-6His-V5. C) blot probed with antibodies for DnaK cytoplasmic 
protein. D) blot probed with antibodies for OmpA outer membrane protein. 
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TraM is Required for Conjugation Within and From B. fragilis LV23 
 
Mutational analysis of CTn341 (another Bacteroides sp CTn) showed that TraM 
is required for Bacteroides conjugal transfer (7). Moreover, if BTF-37 TraM truly 
directly interacts with the two key proteins of the conjugation, the coupling protein BctA 
and the relaxase BmpH, then it is most likely that TraM is essential for Bacteroides 
conjugation. Thus, TraM is most likely essential for B. fragilis conjugation and the 
interaction between TraM and BmpH may be required for TraM function in the CA. 
To determine if TraM is required for B. fragilis conjugation, it is important to 
generate a traM null mutant to study if this strain unable to transfer. A traditional method 
is to use a suicide vector to deliver a TraM disrupted construct from E. coli to B.  fragilis. 
However, this method is difficult and time-consuming due to stringent  recombination 
barriers encountered in B. fragilis. Thus, we decided to suppress the expression of traM 
in B. fragilis by using an antisense RNA (asRNA) approach. AsRNAs have been 
successfully used to suppress the expression of bacterial proteins in several studies, 
especially in the clostridia (118, 125, 138, 143, 177, 178), where very similar difficulties 
are encountered in generating KO mutants. A similar approach was employed to generate 
a traM mutant that decreases in the expression of TraM. 
A shuttle vector carrying an asRNA fragment covering the translation initiation 
site of TraM was generated from the shuttle vector pFD288 (167). The transcription of 
this asRNA gene should be driven by a strong promoter in B. fragilis. However, the 
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promoter present in the shuttle vector pFD288 originated from E. coli and does not work 
in B. fragilis. Moreover, in Bacteroides spp., little is known about promoter properties; 
and it seems that gene promoters in Bacteroides spp. do not possess similar consensus 
sequences like those of E. coli. It has been shown that when the cefoxitin resistance 
(cfxA) gene was introduced into B. fragilis along with an upstream region of 146 
nucleotides, the gene product was strongly expressed for cefoxitin antibiotic selection 
(166). Thus, this 146-nucleotide upstream region of cfxA may contain a strong promoter 
region for this gene. Thus, the shuttle vector was constructed so that it would carry a 
TraM asRNA fragment downstream of cfxA promoter (PcfxA). And the vectors we 
generated were called pFD288MAS1, 2 and 3.  
 
Figure 24. traM-antisense constructs. PcfxA: cefoxitin A promoter. CcR: clindamycin 
resistance (for selection in B. fragilis). SpR: spectinomycin resistance (for selection in E. 
coli). 
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Figure 25. Effect of traM-antisense constructs on conjugation capacity of B. fragilis 
LV23 to recipients B. fragilis TM4000 (in blue) or E. coli HB101 (in red). The 
frequency of the control B. fragilis LV23-pFD288P was set at 100% for comparison with 
test constructs. Other controls pFD288 and pFD351 (pFD288 carrying the whole 
cefoxitin gene) did not show significant effect on conjugation. 
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Quantitatve conjugation experiments from B. fragilis to B. fragilis and from B. 
fragilis to E. coli were carried out to determine if TraM is required for conjugation from 
B. fragilis. Experiments were processed using filters as described in the experimental 
methods. Briefly, in the quantitative conjugation experiments from B. fragilis to B. 
fragilis, B. fragilis strains containing pFD288MAS shuttle vectors or other control 
plasmids were used as donors and B. fragilis TM4000 was the recipients. The donor and 
the recipients were mixed together on Nalgene filters on working bench. Nalgene filters 
containing mixture of cells were aseptically transferred to BHIS agar plates and incubated 
anaerobically overnight. Following incubation, filters were placed in MPBS solution and 
vortexed vigorously to loosen cells and suitable dilutions were plated on selective BHIS 
media (clindamycin for selection of the shuttle vectors in B. fragilis and rifampicin for 
selection of the recipients TM4000). Conjugation frequency was calculated by dividing 
the number of transconjugants obtained by the total number of viable donor cells. Viable 
donor cells were measured by plating serial dilutions of the donor strains onto selective 
medium. Similarly, in the quantitative conjugation experiments from B. fragilis to E. coli, 
B. fragilis strains containing pFD288MAS shuttle vectors or other control plasmids were 
used as donors and E. coli HB101 cells were the recipients. Nalgene filters containing 
mixture of donor and recipient cells were also aseptically transferred to BHIS agar plates 
and incubated anaerobically overnight. After incubation, cells were loosened from the 
filter in MPBS solution and suitable dilutions were plated on selective BHIS media 
(streptomycin and spectinomycin for selection of HB101 and plasmid pFD288, 
respectively). These selective plates were allowed to grow aerobically. Conjugation 
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frequencies were also calculated as described with the quantitative onjugation experiment 
from B. fragilis to B. fragilis. 
Figure 25 shows the results of the quantitative conjugation experiments. Our data 
show that two constructs AS2 and AS3 caused significant impairment to the conjugation 
capacity of B. fragilis LV23. AS2-harboring cells exhibited almost 100% reduction in 
conjugation frequency. AS3 showed up to 75% and 82% conjugation reduction when 
LV23 was mated with B. fragilis TM4000 and E. coli HB101 recipients, respectively. 
These results clearly indicated that TraM was required for conjugation. The AS1 
construct did not reduce conjugation in B. fragilis TM4000 but did so in E. coli HB101 
(up to 100%). This maybe due to several reasons: First, this maybe because AS1 is the 
longest RNA fragment (316nt) with the highest required free energy, ∆G= - 30.7 
kcal/mol (figure 26). This high free energy may cause AS1 secondary structure to be very 
stable and can not relax to bind to and form a complex with traM mRNA. On the other 
hand, AS2 and AS3 have much lower free energy (∆G= - 9.9 kcal/mol and ∆G= - 18.4 
kcal/mol, respectively) (Figure 16). These lower free energy values may allow AS2 and 
AS3 secondary structure to be more flexible to relax and bind to the target traM mRNA. 
Importantly, a TraM-irrelevant control did not show significant alteration in conjugation 
frequency, indicating that the effects of AS2 and AS3 on LV23 conjugation proficiency 
were indeed TraM-specific. Second, the different effects of AS1 on conjugation from B. 
fragilis to B. fragilis and to E. coli may indicate the proficieny of conjugation from B. 
fragilis to B. fragilis is distinct from that to E. coli. Our western blot in Figure 28 showed 
that AS1 did suppressed TraM expression in comparison to the control. However, this 
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suppression is not as strong as that caused by AS2 and AS3 (Figure 28). This data might 
suggest that a certain level of TraM expression is sufficient for conjugation to occur from 
B. fragilis to B. fragilis, however, it may not sufficient for conjugation to occur from B. 
fragilis to E. coli.  
This is the first time an antisense approach has been used to study protein function 
in Bacteroides spp. Because the antisense constructs were designed to cover the 
ribosomal binding site of TraM, it’s most likely that they bind to the mRNA of traM and 
prevent translation of this protein. However, there is also a possibility that the AS bind to 
traM mRNA and direct these transcripts to degradation process. 
 
 
 
Figure 26. The predicted secondary structures of anti-traM AS constructs. The 
predicted structures were obtained by using the Vienna RNAfold engine 
(http://rna.tbi.univie.ac.at/cgi-bin/RNAfold.cgi). 
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Although the quantitative conjugation data showed that TraM was required for 
conjugation, it is needed to determine if these AS constructs were truly specific for traM 
inhibition. If TraM-AS RNAs were indeed gene-specific, then TraM protein production 
would be significantly reduced in the presence of traM AS molecule(s). Moreover, if the 
AS molecules affected TraM expression at the transcriptional level, then both traM 
mRNA transcripts and TraM protein production would be suppressed. But if the AS 
RNAs affected only TraM translation, then traM mRNA transcripts would not be affected 
while protein production would be greatly reduced. Thus, to determine if these AS 
constructs were truly specific for traM inhibition we quantitated the production of traM 
mRNA transcripts as well as the TraM protein level. 
 
Quantitative PCR (Q-PCR) experiments to estimate the level of traM transcripts in the 
presence of different antisense molecules.  
The control for these studies was the B. fragilis LV23 strain that harbored the 
shuttle vector containing only the cefoxitin A (cfxA) promoter (the promoter constructed 
into this shuttle vector to drive the transcription of the antisense constructs). In these Q-
PCR studies, because there was no realiable reference gene to be used in B. fragilis, even 
16S rRNA, the relative expression of tetQ was used as the reference. However because 
tetQ is highly upregulated in conjugation conditions, it is possible that tetQ did not 
equally upregulated at the same level in different cell cultures, resulting in higher 
variation in the results (Figure 27). 
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Q-PCR showed that the effect of ASs on traM is independent from those on 
ORF8 and/or BctA expression (Figure 27). AS1, the AS that did not impair conjugation 
suppressed some traM and bctA transcripts but those effects probably were not significant 
enough to affect conjugation. AS2, the most effective AS seemed significantly suppress 
traM transcripts but not those of ORF8 and bctA. Our data showed that AS2 significantly 
have upregulated effect on the transcript level of ORF8. However, this effect may not be 
real, as discussed above, the use of tetQ as the reference gene for this Q-PCR experiment 
may result in high variations among different samples. If the effect of AS2 on ORF8 was 
real, an evaluation of the protein level of ORF8 is necessary to confirm this data. AS3, 
the AS that suppressed conjugation up to 82% did not seem to have any effect on 
transcription level. However, we do not conclude that AS3 may have effect on translation 
level of traM because complex mechanisms may be involved in the regulation of the 
expression of TraM. 
Our results show that traM expression is indeed specifically down regulated in the 
presence of AS2, and that this results in a corresponding reduction on conjugation 
frequency. TraM is thus required for B. fragilis conjugation. Further, we also conclude 
that the use of an antisense-RNA based option to knock-down gene expression in 
Bacteroides fragilis is a viable approach, and that the nature of the construct (sequence 
and size) is important for consistent and interpretable results.  With the use of appropriate 
controls as described above (multiple target gene AS constructs, non-target gene AS 
construct, and quantitation of gene expression of genes surrounding the target gene) the 
contribution of TraM to B. fragilis conjugation could be rigorously assessed.  
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 A)  traM  B) orf8 
 
Figure 27: Relative expression of A) 
traM mRNA, B) ORF8 mRNA, C) bctA 
mRNA in B. fragilis LV23 cells 
harboring the control plasmid with the 
cefoxitin promoter alone or that 
carrying AS1, AS2 or AS3 construct. 
C) bctA 
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TraM protein expression in the presence of different antisense molecules.  
To determine the protein expression level of TraM in the presence of different 
antisense molecules, we have successfully generated specific antibodies for TraM.  
 
 
 
Figure 28: TraM expression in the presence of AS in B. fragilis membrane fraction. 
About 20 μg of total proteins of B. fragilis membrane fractions were loaded into each 
lane. TM: proteins from B. fragilis conjugation deficient TM4000 strain; P: the control B. 
fragilis LV 23 strain that expression the control vector pFD288P; AS1, AS2 and AS3: 
LV23 strain expressing AS1, AS2 and AS3, respectively. 
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Figure 28 shows expression of TraM in the membrane fraction of B. fragilis LV23 
in the presences of different AS constructs. α-OpmA antibodies were used for the control 
detection of a house keeping protein in the membrane, OmpA. Our data shows that TraM 
is strongly associated in the membrane fraction of B. fragilis, confirming previous 
findings in E. coli. Moreover, our data also confirmed that the protein expression level of 
TraM was indeed significantly reduced in the presence of AS2 and AS3, explaining the 
impairment of DNA transfer in the presence of these antisenses in the quantitative 
conjugation experiments.  
In short, these results show that TraM expression is indeed specifically down 
regulated in the presence of AS2 and AS3, and that these results correspond to the 
reduction in conjugation frequency. TraM is thus required for B. fragilis conjugation.  
 
 
Identification of TraM’s Regions Required for Interactions with BctA and BmpH 
 
Computer analysis of the TraM sequence revealed that some amino acids had 
good probability (P=>50%) of forming coiled-coil structures under physiological 
conditions – these were amino acids 47-75; 106-134; and 150-162 (COILS program 
(109)). Coiled-coil domains are structural motifs commonly involved in protein-protein 
interactions (109). Computer analyses of both BctA and BmpH (our putative coupling 
protein and DNA relaxase, respectively) also showed several predicted coiled-coil 
structures. Thus, we hypothesized that one or more predicted coiled-coil regions of TraM 
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may aid in its interaction with one or more predicted coiled-coil domains of BctA and/or 
BmpH. If this is true, then a TraM mutant protein with a disrupted coiled-coil domain(s) 
should be impaired in its interaction with BctA and/or BmpH, indicating that the 
predicted coiled-coil regions may indeed be required for the interaction. Published data 
strongly support the contention above. A predicted coiled-coil region of an E. coli 
conjugation protein TrhB was shown to be essential for its interaction with the coupling 
protein TraG (57). Further, a coiled-coil domain of the Coprinus cinereus Rad50 protein 
was required for formation of complexes with the exonuclease Mre11; point mutations as 
well as short insertions within the coiled-coil domains of Rad50 reduced or abolished 
function in vivo (1, 83). For these studies (and those proposed below), the specific protein 
structure conferred by the coiled-coil was exploited to study its interaction-conferring 
ability. A coiled-coil region is a heptad repeat of amino acids labeled “a,b,c,d,e,f,g,”, of 
which positions a and d are hydrophobic and form the helix interface that mediates 
interaction with other proteins (Fig 1) (109). Mutagenesis of the amino acid at position(s) 
a or d can disrupt the coiled-coil, and thus alter its interaction with another protein. One 
elegant example of this particular approach is the published study identifying the 
requirement of two amino acids at position a and d of a coiled coil domain of the 
Neurospora sp protein FRQ for its dimerization (27). In this study, alteration of the 
hydrophobic amino acid Leucine at position a or d to a hydrophilic amino acid Arginine, 
weakened or abolished the intra-subunit interaction(27). Another example is the study 
that identified the requirement of amino acids at position a or d within the coiled-coil 
domain of the E. coli protein EspA for its oligomerization (40). Similar site directed 
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mutagenesis approaches were used to identify interacting regions within a coiled-coil 
domain required for oligomerization of the Enterococcus faecalis DivIVA protein (148), 
and dimerization of the  E. coli MukB protein, (101). 
 
Based on the published studies above, we hypothesized that if coiled- coil 
domains were indeed required for TraM interaction with BctA/ BmpH, and if 
hydrophobic amino acids at position a or d of the heptad were mutated to hydrophilic 
amino acids, the coiled-coil structure would be disrupted, leading to an impairment of 
protein-protein interaction(s). Usually, to determine if a coiled-coil structure is disrupted, 
circular dichroism (CD) and melting temperature experiments are performed to measure 
the helicity and stability of the protein (101). Since our current infrastructure does not 
allow us to perform such experiments, we proposed to use site-directed mutagenesis of 
multiple amino acids at position a or d of a predicted TraM coiled-coil domain, followed 
by bacterial two-hybrid screens and far-western analyses to determine if those specific 
TraM amino acids were required for its interaction with BctA/BmpH. 
 
 
Figure 29. Coiled coil heptad amino acid 
arrangement of two partner proteins. 
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To test if an amino acid (aa) at position a or d of the three predicted coiled-coil 
regions of TraM is required for its interaction with BctA or BmpH, we used site directed 
mutagenesis to alter that hydrophobic amino acid to a more hydrophilic aa, in an effort to 
disrupt the coiled-coil structure. Potential coiled-coil domains are designated A, B and C 
(figure 30). There are 22 amino acids at positions a and d in these three predicted coiled-
coil regions of TraM. The COILS program was used to identify amino acids, which when 
mutated, would cause the most significant reduction in the probability of forming coiled-
coils. Thus, amino acid at position F66, L69 (region A), L123 (region B) and M154 
(region C) were selected for mutagenesis studies. If an amino acid of the predicted 
coiled-coil region is required for the interaction, its mutants should show different 
interaction strengths with BctA and/or BmpH. Mutation to a stronger hydrophobic amino 
acid is expected to strengthen the interaction of TraM with its partner protein. 
Conversely, mutation to a weaker hydrophobic or hydrophilic amino acid is expected to 
 
Figure 30. TraM and predicted coiled coil regions. Green areas are 
hypothetical coiled coil regions. Potential coiled coil regions are designated 
as A, B, and C.  
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impair the interaction(s). The interactions of most important mutants were further 
biochemically confirmed by Far western analyses. The expression of TraM mutants were 
also tested by western blot, showing that they were stably expressed.  
 
TraM’s amino acid F66 and L123 are required for interaction with BctA 
Figure 31 shows the bacterial two-hybrid analysis of the interactions of different 
TraM mutants with BctA. The control was the interaction of the wild type TraM with 
BctA. Western blots were performed to confirm that all of the mutants were made and 
stable. A western blot showing the expression of the most significant mutants was shown 
in Figure 33, blot 3. The multiple bands observed in this blot are degradation products of 
TraM, which were commonly observed when TraM was expressed under induction 
conditions. As can be seen from Figure 31, mutations of amino acid (aa) F66 in region A 
and amino acid L123 in region B significantly impaired the interaction of TraM with 
BctA, while other mutations did not. As expected, alterations to amino acids of increased 
hydrophilicity resulted in greater impairment of protein-protein interactions. These results 
thus strongly suggest that F66 and L123 are involved in the interaction of TraM with 
BctA, and that the chosen amino acids in region C are not. 
Moreover, Far Western analyses of mutants F66R, L123R and L123S also 
revealed significantly reduced interactions between TraM and BctA (Figure 33). 
Together with the bacterial two-hybrid data presented above, there is now sufficient 
evidence confirming that amino acid F66 and L123 are indeed involved in the interaction 
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between TraM and BctA, and that TraM, via interaction with the coupling protein BctA, 
is required for DNA transfer from B. fragilis to other bacteria. 
 
TraM’s amino acid L123 is required for interaction with BmpH 
Bacterial two hybrid analyses of TraM mutants and the relaxase BmpH as can be 
seen from Figure 32 revealed that the specific TraM amino acids chosen for mutagenesis 
(except one – L123S) above did not affect/alter the interaction between the two proteins. 
Interestingly, the L123S mutant showed an increase up to 50% in its interaction strength 
with BmpH compared to that of the white type TraM. This significant alteration suggests 
that L123 may also be involved in the interaction between TraM and BmpH, but in a 
manner that facilitates protein contact. 
Far western experiments also confirmed the strong interaction of mutant L123S 
with the relaxase BmpH. The interactions of TraM and other mutants (F66R and L123R) 
with BmpH are not detectable in a far western experiment. This may be due to two 
reasons. First, the interaction between TraM and BmpH may not be as strong as that with 
BctA. Second, under the purification conditions used, BmpH molecules may not be fully 
non-denatured, hindering its interactions with other proteins on the membrane. Even 
though the amount of purified BmpH used for overlaying the blot was increased from 10 
μg to 30 μg, it was still not sufficient to detect the interaction of BmpH with TraM. 
The above data strongly suggest that L123 may also be involved in the interaction 
between TraM and BmpH. The same amino acid may be a target for competition between 
two interacting partners, the coupling protein BctA and the relaxase BmpH. If this is true, 
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there may be a regulatory mechanism(s) to control the strength of interaction of TraM 
with either BctA or BmpH when needed. Indeed, the lowered strength of interaction seen 
with wild-type TraM and BmpH as opposed to L123S-BmpH may actually be required 
for rapid DNA transfer, where interacting complexes may need to be generated and dis-
assembled in a dynamic fashion.  
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Figure 31: Bacterial two hybrid analysis of interactions of TraM mutants with BctA. 
Mutants tested for region A were: F66A, F66G, F66R, L69A, L69G and L69R. In region 
B, tested mutants were: L123A. L123G. L123R and L123S. In region C: tested mutants 
were: M154A, M154G and M154R.  
 
Figure 32: Bacterial two hybrid analysis of interactions of TraM mutants with 
BmpH. 
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Figure 33: Far western analysis of the interactions between λ-cI-TraM mutants and 
BctA or BmpH. Cells: XL-1 Blue cell lysate. pBT: cell lysate of XL-1 Blue cells that 
carried pBT vector alone. Wild type TraM and other mutants were expressed in pBT 
vector in XL-1 Blue cells. Blot 1: Overlaid with 10 μg of natively purified 6His-BctA, 
Blot 2: overlaid with 30 μg of natively 6His-BmpH, 3: Detection of λ-cI-TraM with α-
TraM antibodies, 4: Non-specific control blot with α-His antibodies. The multiple bands 
seen in blot 3 are degradation products of TraM, which were commonly observed under 
induction condition. 
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CHAPTER V  
DISCUSSION 
 
 
BctA is Essential for Conjugation from B. fragilis LV23  
 
Although many conjugative mobile elements have been identified in Bacteroides 
spp., none of the core components of the transfer regions of these elements have been 
characterized in detail except BctA of BTF-37 (77). BctA of BTF-37 and its homolog 
TraG (OrfG) in other Bacteroides conjugative transposon systems (B. thetaiotaomicron 
CTnDOT, CTnERL and CTnXBU422) have long been predicted to be coupling proteins 
of Bacteroides CA (150). All of the above proteins exhibit characteristics of coupling 
proteins: they have Walker box (ATPase) motifs, a DNA binding motif, they are 
associated with the membrane when expressed in E. coli (BctA of BTF-37 (77) and TraG 
of CTnDOT (191)) and their expressions upregulated under conjugation conditions (BctA 
of BTF-37 (77)). Furthermore, BctA has been shown to be a tetramer (77), which would 
allow it to form a ring structure at the base of the membrane like other described coupling 
proteins (TrwB of R388 system (58), TraD of F system (72), TraG of RP4 system (156), 
and VirB4 of Ti system (115)). However, there were still not enough data to confirm that 
BctA and its TraG homologs were indeed bona fide coupling proteins in Bacteroides spp. 
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conjugation systems, since their ATPase activity was not determined, and gene knock-
outs were not available. In this study, we further showed that the putative coupling 
protein BctA was essential for conjugation mediated by the conjugative transposon BTF-
37. This is another important piece of evidence to further indicate the role of a coupling 
protein of BctA in B. fragilis. Experiments to investigate the requirement of BctA Walker 
A and B motifs and their ATPase activities for conjugation need to be further carried out.  
Moreover, it is known that the CP acts as a “gate-keeper” of the CA system. One 
of its important roles is to recognize and interact with the cognate relaxosome. This is the 
first step for the transfer of the relaxosome through the CA. In many conjugative systems 
including the E. coli F plasmid and A. tumefaciens Ti plasmid, the coupling protein is 
highly selective for the respective cognate relaxosome (73, 155). CPs of other E. coli 
systems like RP4 and R388 (though less selective)  still only interact with their own 
cognate relaxosomes and closely related plasmids (73). In contrast, Bacteroides 
conjugative transposons are known for non-selective or permissive transfer of DNA. 
DNA from different bacterial origin (from E. coli or from other Bacteroides species) can 
be easily transferred by Bacteroides CTns. Meanwhile, our data show that when bctA was 
deleted, no transfer could occur. This result indicates that BctA is a key component to 
determine the permissive characteristic of B. fragilis CA for different types of transfer 
DNA (180). Although the precise molecular mechanism of relaxosome recognition by the 
CP has not been fully defined, our result still indicates that Bacteroides CP is unique and 
different from that of E. coli and A. tumefaciens. This non-specificity feature is the key 
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for the easy and promiscuous dissemination of mobile elements carrying antibiotic 
resistance genes from B. fragilis to other bacteria. 
 
 
BTF37 Genes are Involved In Conjugation Process in B. fragilis LV23 
 
To investigate the involvement of all ORFs in the known 16 kb region of BTF-37 
contig, we examined the transcriptional expression of these ORFs under conjugation 
conditions by RT-PCR. Our results reveal that all 11 genes are up-regulated under 
conjugation induction conditions, suggesting that all known BTF-37 contig genes are 
involved in the conjugation process. They are most likely predicted CA proteins. These 
ORFs show similarity to respective putative conjugative genes in other Bacteroides 
conjugative systems, such as B. thetaiotaomicron CTnDOT and B. vulgatus CTn34. 
However, no homology has been found for these genes with conjugation genes of E. coli 
or A. tumefaciens. In contrast, conjugation systems in E. coli, A. tumefaciens and even in 
some other gram negative species always exhibit some homologous components (2). 
Thus, the fact that B. fragilis BTF-37 CA components are not homologous to that of other 
genera further strengthens the idea about the unique and distinguishing nature of 
Bacteroides conjugation system. It therefore becomes all the more necessary to fully 
understand the structure and molecular mechanism of Bacteroides conjugation. Only a 
full understanding of the Bacteroides conjugation process can help design suitable 
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interventions to inhibit the dissemination of antibiotic resistance genes from Bacteroides 
spp. to other bacteria. 
 
TraM and TraN are Identified as Components of B. fragilis CA 
 
As a “gate-keeper” of the DNA transfer process, the CP does not just interact with 
the relaxosome but also with some components of the CA. In A. tumefaciens, the CP 
VirB4 has been shown to interact with other ATPases like VirD4, VirB11 and other non-
ATPase components of the CA like VirB8 and VirB3 (47). In E. coli R27 plasmid, a F-
type  system, the CP TraGH has been shown to have interactions with TrhBH, another 
multimeric protein that may form a ring structure to extend the pore of the coupling 
protein into the periplasmic space (57). This CP also interacts with other CA components 
like TrhEH and TrhIH (92).  
In the search for CA components that interact with the CP BctA, we have found 
that BctA interacts with two gene products, ORF7 (TraM) and ORF8 (TraN). In bacterial 
two-hybrid analyses, BctA interacts most strongly with TraM. The interaction with TraN 
is weaker. This is an early step in understanding CA protein contacts in B. fragilis. If 
TraM and TraN truly interact with BctA, then they are most likely localized in the 
membrane, close to BctA as well as to the base of the CA, and may be important 
components of the CA. In fact, we demonstrated that TraM indeed interacts with BctA 
and it is localized to the inner membrane. Further biochemical studies are required to 
determine if TraN truly interacts with BctA.  
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Moreover, further studies are required to find other components of CA, to 
determine how they interact, and how are they are regulated to ensure complex function 
of the CA. These components might be other ORFs of the 16 kb BTF-37 contig and 
interact with TraM or TraN. They may be unkown ORFs in the unkown sequence of 
BTF37. A bacterial two hybrid analysis for the interaction of BctA with B. fragilis LV23 
genomic library will help identifying all possible interacting partners of BctA. Moreover, 
a similar genomic library screening can also be carried out to identify all possible 
interacting partners of TraM or TraN. In these experiments, a genomic library of B. 
fragilis LV23 can be generated by purifying the strain genomic RNA and randomly 
amplifying this genomic RNA with short, random nucleotide primers. This genomic 
library can be randomly constructed into the target vector of the bacterial two hybrid 
system and then a normal bacterial two hybrid analysis will be carried out. Any positive 
colonies that show interaction with the bait (BctA, TraM or TraN) will be collected and 
the putative gene that interacts with the bait will be sequenced by using specific primers 
for the target vector.  
An alternative approach to identify other components of the CA is to amplify the 
whole BTF-37 CTn and generate a random library of BTF-37 genes by random PCR, 
then perform a bacterial two hybrid library screening. It is now possible to amplify this 
37 kb fragment by using specific polymerase kits for long fragment amplification from 
Biorad. Another method is to use transposon insertion to generate a random library of 
BTF37 CTn. 
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TraM Localization, Interactions and Function in B. fragilis CA  
 
Our bacterial two-hybrid analysis and Far Western experiments show that TraM 
interacts with both the CP BctA and the relaxase BmpH; this is the first report of an 
interaction between a CA component with a CP in Bacteroides spp. This is also the first 
demonstration of an interaction of a CA protein other than a CP with the relaxosome (via 
interaction with the relaxase).  
In the A. tumefaciens Ti plasmid sytem, E. coli RP4 and F plasmid systems and in 
other species, the relaxase may complex with other partners, but they are not involved in 
the CA (89). For example, in the F plasmid system, the relaxase TraI interacts with 
partners like IHF, TraY and TraM but none of them are core components of the CA 
(142). In contrast, in A. tumefaciens, the relaxase VirD2 has not been found to have 
interaction(s) with any other component of the CA other than with the CP (29). Thus, the 
demonstration of the interaction of TraM, a component of the CA, with BmpH, a 
relaxase, is a new finding, supporting the idea that the molecular mechanism of 
conjugation in Bacteroides spp. is distinct from that of E. coli and other species.  
In addition, the relaxosome of Bacteroides spp. in general requires far fewer 
numbers of proteins for DNA processing than E. coli (95, 130). There are two examples 
in which Bacteroides spp. relaxosomes have only one DNA processing protein. They are 
BmpH of Tn5520 and MobA of Tn4555 (165, 182). Therefore, it is highly possible that 
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TraM may support the direction of relaxosome complex through the mating channel by 
interacting with the relaxase BmpH. 
The triad nature of the interactions of TraM with BctA and/or BmpH also 
suggests that TraM may act as a helper for both BmpH and BctA to facilitate movement 
of the relaxosome through the CA channel. In fact, the finding that amino acids F66 and 
L123 in TraM two predicted coiled-coil domains are required for interaction with BctA 
indicate that TraM interaction with BctA may be important for conjugation. Moreover, 
these two amino acids may be essential for TraM function in mediating DNA transfer in 
B. fragilis. Further examination of the requirement of these amino acids for conjugation 
in B. fragilis is required to test these hypotheses. To test these hypotheses, first, a B. 
fragilis traM null mutant must be generated. Then, different TraM mutants should be 
introduced for expression into the traM null mutant. Finally, quantitative conjugation 
experiments will be carried out to investigate the impacts of TraM mutants on 
conjugation proficiency of B. fragilis. If it is true that amino acid F66 and L123 are 
required for TraM interaction with BctA and if this interaction is important for DNA 
transfer, then we expect to observe a significant defect in the DNA transfer capacity of B. 
fragilis in the presence of TraM mutants. In addition, it is important to determine the 
regions on BctA and BmpH that are required for interaction with TraM. This can be 
performed by using a mutator strain such as E. coli XL-1 Red to generate libraries of 
BctA and BmpH mutants then analyse the interactions of the mutants with TraM by using 
a bacterial two hybrid library screening. The mutants that show significant defect on 
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interaction of BctA/ BmpH with TraM will also be further investigated for their 
requirements for DNA transfer in B. fragilis.  
A recent cryo-EM structure of the core conjugation complex from E. coli 
pKM101 shows that the CA core complex spans from the inner to the outer membranes, 
and is formed by the different components TraN/VirB7, TraO/VirB9 and TraF/VirB10 
(48). The inner layer of the T4SS in A. tumefaciens was speculated to be composed of 
VirB6 and VirB8 because these proteins interact directly with the transfer T-DNA (47). 
Thus, in the B. fragilis conjugation system, and along with the interaction with the 
relaxase BmpH and localization to the inner membrane, TraM may also be a component 
of the inner ring complex like VirB6 and VirB8. An investigation by using cryo-EM or 
X-ray crystallography approaches to examine the 3D structure of TraM will reveal this 
speculation. Moreover, to investigation TraM possible oligomerization nature, a 
molecular mass determination of TraM can be performed as previously described (77). In 
this experiment, TraM will be purified under non-denature condition and then 
electrophoresed under native condition. A Ferguson plot for analysis of migration ratios 
of TraM possible species will be performed to calculate their molecular weights.   
Moreover, the finding that the same amino acid L123 is required for TraM 
interaction with both BctA and BmpH indicates a possible regulatory mechanism for 
interaction of TraM with BctA or BmpH to facilitate DNA transfer efficiency in B. 
fragilis. A very complicated regulatory system of many different CA proteins has been 
defined in IncF plasmid (including F, R100 and pRK100) conjugation (49). In 
Bacteroides spp., the regulatory cascade tetQ-rteA-rteB and rteC is responsible for 
  
136
controlling the excision of CTnDOT (122). It was thought that RteC also regulates tra 
gene expression. However, recently, it has been demonstrated that the expression of 
CTnDOT transfer genes is activated by the excision proteins, independent of RteC (84). 
All of these reported regulatory systems suggest that the regulatory mechanism of 
conjugation is complicated and that there may be more new mechanisms that need to be 
explored.  
Thus, we propose multiple models for a controlled regulatory system in which 
TraM switches interactions between BmpH and/to BctA (Figure 34). In the first model, 
model A, TraM is anchored in the inner membrane and interacts with BctA in normal 
conformation. When the relaxasome heads to the CA, TraM may change conformation to 
interact with BmpH first, assist the relaxasome to interact with BctA to translocate 
through the CA. On the other hand, a second model, model B, would be one in which 
TraM is a part of the inner ring of the CA and interacts with BctA in its normal 
conformation after the CA is formed to maintain the CA ring structure. However, when 
the relaxosome passes through the gate (BctA), TraM may change conformation, 
allowing interaction with BmpH to assist the movement of the relaxosome. It is also 
possible that multi copies of TraM may present in the actual CA structure. A 3D crystal 
structure of TraM, BctA and BmpH will solve this question. 
To distinguish the above proposed models, several approaches can be employed. 
First, a 3D crystal structure of the whole CA complex with the presence of TraM, BctA 
and BmpH may show the exact localization of TraM in this triad relationship. Second, a 
time-line cryo-EM or X-ray crystallography experiment can be carried out to freeze the 
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movements of the relaxosome and the conformation changes of TraM. This experiment 
will show whose protein, BctA or TraM will contact with the relaxosome first. Third, the 
DNA to be transferred can be radio-label and then the contact of the DNA with CA 
components can be captured with time-line procedure and DNA binding assay such as 
mobile shift gel electrophoresis to determine which protein will contact with the 
ralaxosome first (via interaction with BmpH or the DNA).   
  
138
 
  
Model A Model B 
 
Figure 34. Predicted localization of TraM, model A. The red arrow shows the direction 
where the relaxosome directed by BmpH will pass through during conjugation. Model A: 
TraM is localized in the inner membrane and interacts with BctA in normal 
conformation. When the relaxasome heads to the CA, TraM may change conformation to 
interact with BmpH, assist the relaxasome to interact with BctA to translocate through the 
CA. Model B: TraM, as a member of the inner ring of the CA, interacts with BctA in 
normal conformation to maintain the CA ring structure. When the relaxosome passes 
through the gate (after contacting with BctA), TraM may change conformation, allowing 
interaction with BmpH to assist the movement of the relaxosome through the CA. 
Adapted from Christie, Nature, 2009 (28).  
  
139
Furthermore, the finding that the AS1 construct showed different effects on 
conjugation frequencies from B. fragilis to B. fragilis and to E. coli, suggesting that the 
required conjugation machine for transfer to B. fragilis may be different for E. coli. The 
fact that AS1 can suppress the transfer to E. coli up to 100% in comparison to the control, 
while does not have effect on the transfer to B. fragilis, indicates that a certain level of 
TraM production may be enough for transfer to occur from B. fragilis to B. fragilis. But a 
much higher level of TraM production may be required for transfer from B. fragilis to E. 
coli. This speculation may make sense as more energy may be required for conjugation to 
occur to a different genus. An experiment in which TraM expression level can be 
controlled by an induced agent may help verify this speculation. In this experiment, a B 
fragilis traM null mutant must be generated. Then, TraM will be introduced into B. 
fragilis via an expression vector, in which TraM expression can be controlled by an 
induced agent. Under non-induction condition, there should be a leaky expression of a 
small amount of TraM. However, when the induced agent is used, TraM expression is 
upregulated. Quantitative conjugation of different TraM production levels will be carried 
out to determine the required level of TraM for conjugation to occur to B. fragilis and to 
E. coli.  
In short, further investigation is required to obtain more in-depth knowledge of 
the requirements of amino acids F66 and L123, and the possible regulatory relationship 
of the interactions of TraM with BctA and BmpH for DNA transfer in B. fragilis. A 
further mutagenesis study is required to identify the region of BctA and BmpH required 
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for the interaction with TraM. Moreover, these mutants need to be examined by 
quantitative conjugation in B. fragilis to confirm the requirement of these interactions for 
DNA transfer in B. fragilis. Due to difficulty in genetically modifying B. fragilis 
chromosomal genes, work in this dissertation did not attempt such experiments. 
However, in the future, when we have the right tools, it would be informative for B. 
fragilis conjugation studies to pursue this direction. 
 
 
TraM is Required for Conjugation in B. fragilis and Application of Antisense RNA  
 
By using antisense RNA tools, we further confirmed the requirement of TraM for 
DNA transfer within B. fragilis and from B. fragilis to E. coli. This is the first time an 
antisense RNA approach has been applied in B. fragilis to knock down expression of a 
target gene to investigate its function. This method helped overcome the difficulty 
encountered in generating a traditional knock-out mutant in Bacteroides spp. Previously, 
antisense RNAs also have been successfully used to suppress the expression of bacterial 
proteins in several studies, especially in the clostridia (118, 125, 138, 143, 177, 178), 
where very similar difficulties are encountered in generating knock-out mutants. This 
technology proved to be efficient and will be useful for future study in anaerobes.  
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Future perspective 
 
As the most prominent group of bacteria residing in the gut and as those that also 
harbor a plethora of transmissible genetic elements carrying many antibiotic resistance 
genes, Bacteroides spp. have long been considered as a reservoir for the dissemination of 
antibiotic resistance traits to other bacteria. With the alarming rise and spread of 
antibiotic resistance to even new generation of antibiotics, the need to prevent the 
dissemination of antibiotic resistance has become more urgent. Because conjugation is 
the major means for bacteria, especially Bacteroides spp., to disseminate antibiotic 
resistance genes to other bacteria, effective intervention targets this process is an 
appropriate approach. Currently, many groups are exploring non-antibiotic-based 
methodologies to prevent conjugation-based DNA transfer (45, 51, 107, 111, 180). 
Different ways to inhibit the conjugative ralaxase have been tested in laboratories. 
Antibody libraries against the relaxase TrwC of conjugative plasmid R388 can be used to 
block relaxase activity within recipient cells (51). Other studies report being able to 
disrupt the conjugation process by using specific inhibitors to the conjugative relaxase of 
the F plasmid (107). Interestingly, a short palindromic repeat (CRISPR) RNA 
interference can also limit gene transfer – this has been tested in Staphylococci by 
targeting relaxase genes (111). Overall, the search for better antibiotic resistance 
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interventions targeting conjugation is promising. Our study provides a better 
understanding of the B. fragilis conjugation system. This will be useful for the design of 
appropriate drugs to intervene with the conjugation process in Bacteroides spp., and 
ultimately inhibit the spread of antibiotic resistance genes from this genus to other 
bacteria. 
 
Significance 
 
In conclusion, this study represents the first in-depth characterization of a 
conjugal apparatus protein, TraM, in B. fragilis, which will be useful for future studies 
aimed at developing interventions to prevent dissemination of antibiotic resistance from 
Bacteroides spp. to other bacteria. This is the first demonstration of interactions of a CA 
protein with a CP and a relaxase in B. fragilis. Moreover, this is one of very few studies 
using RNA antisense technology to knock-down target gene expression in anaerobes, 
avoiding the difficulties encountered in modifying genes in these genera.  
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